UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM N-CSR
Investment Company Act file number: 811-07507
Deutsche DWS Investments VIT Funds
(Exact Name of Registrant as Specified in Charter)
875 Third Avenue
New York, NY 10022-6225
(Address of Principal Executive Offices) (Zip Code)
Registrant’s Telephone Number, including Area Code: (212) 454-4500
Diane Kenneally
100 Summer Street
Boston, MA 02110
(Name and Address of Agent for Service)
Date of fiscal year end: | 12/31 |
| |
Date of reporting period: | 12/31/2023 |
ITEM 1. | REPORT TO STOCKHOLDERS |
| |
| (a) |
December 31, 2023
Annual Report
Deutsche DWS Investments VIT Funds
Contents
This report must be preceded or accompanied by a prospectus. To obtain an additional prospectus or summary prospectus, if available, call (800) 728-3337 or your financial representative. We advise you to consider the Fund’s objectives, risks, charges and expenses carefully before investing. The summary prospectus and prospectus contain this and other important information about the Fund. Please read the prospectus carefully before you invest.
Stocks may decline in value. Various factors, including costs, cash flows and security selection, may cause the Fund’s performance to differ from that of the index. Smaller company stocks tend to be more volatile than medium-sized or large company stocks. The Fund may lend securities to approved institutions. Investing in derivatives entails special risks relating to liquidity, leverage and credit that may reduce returns and/or increase volatility. Please read the prospectus for details.
War, terrorism, sanctions, economic uncertainty, trade disputes, public health crises, natural disasters, climate change and related geopolitical events have led and, in the future, may lead to significant disruptions in U.S. and world economies and markets, which may lead to increased market volatility and may have significant adverse effects on the Fund and its investments.
The Fund is not in any way connected to or sponsored, endorsed, sold or promoted by the London Stock Exchange Group plc and its group undertakings (collectively, the "LSE Group"). FTSE Russell is a trading name of certain of the LSE Group companies. All rights in the Russell 2000 Index (the "Index") vest in the relevant LSE Group company which owns the Index. "FTSE® ""Russell ®" and "FTSE Russell®" are trademarks of the relevant LSE Group company and are used by any other LSE Group company under license. The Index is calculated by or on behalf of FTSE International Limited, FTSE Fixed Income, LLC or their affiliates, agents or partners. The LSE Group does not accept any liability whatsoever to any person arising out of (a) the use of, reliance on or any error in the Index or (b) investment in or operation of the Fund. The LSE Group makes no claim, prediction, warranty or representation either as to the results to be obtained from the Fund or the suitability of the Index for the purpose to which it is being put by DIMA.
The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc. which offers investment products or DWS Investment Management Americas, Inc. and RREEF America L.L.C. which offer advisory services.DWS Distributors, Inc., 222 South Riverside Plaza, Chicago, IL 60606, (800) 621-1148
NOT FDIC/NCUA INSURED NO BANK GUARANTEE MAY LOSE VALUE
NOT A DEPOSIT NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCY
Performance SummaryDecember 31, 2023 (Unaudited)
Fund performance shown is historical, assumes reinvestment of all dividend and capital gain distributions, and does not guarantee future results. Investment return and principal value fluctuate with changing market conditions so that, when redeemed, shares may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted. Please contact your participating insurance company for the Fund’s most recent month-end performance. Performance figures for Classes A and B differ because each class maintains a distinct expense
structure. Performance does not reflect charges and fees (“contract charges”) associated with the separate account that invests in the Fund or any variable life insurance policy or variable annuity contract for which the Fund is an investment option. These charges and fees will reduce returns.
The gross expense ratios of the Fund, as stated in the fee table of each prospectus dated May 1, 2023 are 0.42% and 0.72% for Class A and Class B shares, respectively, and may differ from the expense ratios disclosed in the Financial Highlights tables in this report.
Generally accepted accounting principles require adjustments to be made to the net assets of the Fund at period end for financial reporting purposes only, and as such, the total return based on the unadjusted net asset value per share may differ from the total return reported in the financial highlights.
Growth of an Assumed $10,000 Investment
Yearly periods ended December 31
Russell 2000® Index is an unmanaged, capitalization-weighted measure of approximately 2,000 of the smallest companies in the Russell 3000® Index.
The Russell 3000® Index is an unmanaged index that measures the performance of the 3,000 largest U.S. companies based on total market capitalization, which represents approximately 98% of the investable U.S. equity market.
Index returns do not reflect any fees or expenses and it is not possible to invest directly into an index.
|
| | | | |
| | | | | |
Average annual total return | | | | |
| | | | | |
Average annual total return | | | | |
| | | | |
| | | | | |
Average annual total return | | | | |
| | | | | |
Average annual total return | | | | |
The growth of $10,000 is cumulative. |
Management Summary December 31, 2023 (Unaudited)
The Fund returned 16.76% (Class A shares, unadjusted for contract charges) for the 12 months ended December 31, 2023, while the Russell 2000® Index returned 16.93%. The difference in performance is typically driven by transaction costs and Fund expenses. The Fund periodically invests in equity index futures in order to keep the portfolio’s positioning in line with that of the index. This strategy had a neutral impact on performance.
U.S. equities delivered positive returns in 2023, with much of the gain occurring in November and December. For most of the year, the market experienced volatility based on the shifting expectations for economic growth and U.S. Federal Reserve (Fed) policy. However, a drop in oil prices and a series of better-than-expected inflation reports contributed to a sizable rebound in investor sentiment in November. Stocks surged in response, and the rally accelerated in December after Fed Chairman Jerome Powell suggested that the Fed may begin to cut rates as soon as the first half of 2024. Additionally, positive growth data led to mounting optimism that the U.S. economy could avoid a recession.
The Russell 2000 Index underperformed the 26.53% return for the large-cap Russell 1000® Index in 2023. Small caps are more likely to require capital than established firms, so the prospect of higher rates was a headwind for relative performance over the first ten months of the year. However, smaller companies strongly outperformed from the beginning of November onward once concerns about the interest-rate outlook began to dissipate.
Although growth stocks outpaced their value counterparts in the large-caps space — a result of outsized returns for a narrow group of technology-related stocks — the performance of the two categories was much closer within the small-cap universe. The Russell 2000® Growth Index returned 18.66% for the year, while the Russell 2000® Value Index gained 14.65%.
Ten of the 11 sectors in the Russell 2000 Index produced gains in 2023. Utilities, which were hurt by their above-average interest rate sensitivity, was the only sector to finish in the red. However, the impact on headline index returns was limited due to the sector’s modest weighting. Consumer discretionary, information technology, and industrials were the three top-performing sectors. Given that the economy held up better than investors had anticipated at the start of the year, the more economically sensitive segments of the market generally led the way higher. Consumer staples was the only other sector to outperform the index, with a sizable contribution coming from strength in food & beverage companies. Materials stocks, while also benefiting from better-than-expected economic growth, finished just behind the index. Real estate also lagged somewhat in the rising-rate environment, but the sector closed well off of its October lows on the strength of an impressive rally in the final two months of the year. The financials, energy, communication services, and healthcare sectors, while finishing the year firmly in positive territory, also failed to keep pace with the broader market.
Brent Reeder
Senior Vice President, Northern Trust Investments, Inc., Subadvisor to the Fund
Portfolio Manager
The views expressed reflect those of the portfolio management team only through the end of the period of the report as stated on the cover. The management team’s views are subject to change at any time based on market and other conditions and should not be construed as a recommendation. Past performance is no guarantee of future results. Current and future portfolio holdings are subject to risk.
Terms to Know
The Russell 2000 Index is an unmanaged, capitalization-weighted measure of approximately 2,000 of the smallest companies in the Russell 3000® Index. The Russell 3000 Index is an unmanaged index that measures the performance of the 3,000 largest U.S. companies based on total market capitalization, which represents approximately 98% of the investable U.S. equity market.
The Russell 1000 Index is an unmanaged index that measures the performance of the 1,000 largest companies in the Russell 3000 Index, which represents approximately 92% of the total market capitalization of the Russell 3000 Index.
The Russell 2000 Growth Index is an unmanaged capitalization-weighted measure of 2,000 of the smallest capitalized U.S. companies with a greater-than-average growth orientation and whose common stocks trade on the NYSE, NYSE Alternext U.S. (formerly known as “AMEX”) and NASDAQ.
The Russell 2000 Value Index is an unmanaged index that measures the performance of the small-cap value segment of the U.S. equity universe.
Index returns do not reflect any fees or expenses and it is not possible to invest directly into an index.
Futures contracts are contractual agreements to buy or sell a particular commodity or financial instrument at a predetermined price in the future.
Consumer discretionary stocks represent companies that make and market goods and services that are considered non-essential. Sub-categories within the consumer discretionary sector include retailers, media, consumer services, consumer durables & apparel, and automobiles.
Consumer staples stocks represent companies that make products purchased by consumers on a regular basis, such as food and beverages, prescription drugs, and household products. In the aggregate, sales of consumer staples tend to be steady and less sensitive to economic fluctuations.
Portfolio Summary(Unaudited)
Asset Allocation (As a % of Investment Portfolio excluding Securities Lending Collateral) | | |
| | |
| | |
Government & Agency Obligations | | |
| | |
| | |
| | |
| | |
Sector Diversification (As a % of Common Stocks, Rights and Warrants) | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Ten Largest Equity Holdings at December 31, 2023 (3.2% of Net Assets) |
1Super Micro Computer, Inc. | |
Designs, develops, manufactures and sells server solutions based on modular and open-standard architecture | |
2Simpson Manufacturing Co., Inc. | |
Designs, engineers, manufactures connectors and sheer walls | |
| |
Operates as a clinical stage biopharmaceutical company | |
| |
Operates as a cosmetic company and offers products for eyes,lips,and face | |
| |
Provider of enterprise software platforms around the world | |
| |
Designs, manufactures, and markets wood and non-wood composites, and other materials | |
| |
Provider of gaming and lottery services | |
| |
Manufacturer of film thickness and overlay metrology systems | |
| |
Manufacturer of semiconductor equipment | |
10Comfort Systems U.S.A., Inc. | |
Provider of heating, ventiliation, and air conditioning system installation, maintenance, repair, and replacement services | |
Portfolio holdings and characteristics are subject to change.
For more complete details about the Fund’s investment portfolio, see page 6.
Following the Fund’s fiscal first and third quarter-end, a complete portfolio holdings listing is posted on dws.com and is available free of charge by contacting your financial intermediary or, if you are a direct investor, by calling (800) 728-3337. In addition, the portfolio holdings listing is filed with the SEC on the Fund’s Form N-PORT and will be available on the SEC’s Web site at sec.gov. Additional portfolio holdings for the Fund are also posted on dws.com from time to time. Please see the Fund’s current prospectus for more information.
Investment Portfolioas of December 31, 2023
| | |
| |
Communication Services 2.3% | |
Diversified Telecommunication Services 0.5% | |
| | | |
AST SpaceMobile, Inc.* (a) | | | |
| | | |
| | | |
Charge Enterprises, Inc.* | | | |
Cogent Communications Holdings, Inc. | | | |
Consolidated Communications Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
Liberty Latin America Ltd. "A"* | | | |
Liberty Latin America Ltd. "C"* | | | |
Lumen Technologies, Inc.* | | | |
| | | |
Shenandoah Telecommunications Co. | | | |
| | | |
| |
Atlanta Braves Holdings, Inc. "A"* | | | |
Atlanta Braves Holdings, Inc. "C"* | | | |
| | | |
| | | |
Lions Gate Entertainment Corp. "A"* | | | |
Lions Gate Entertainment Corp. "B"* | | | |
| | | |
Madison Square Garden Entertainment Corp.* | | | |
| | | |
| | | |
| | | |
Sphere Entertainment Co.* | | | |
| | | |
| | | |
Interactive Media & Services 0.7% | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
Advantage Solutions, Inc.* | | | |
| | | |
| | | |
| | | |
Clear Channel Outdoor Holdings, Inc.* | | | |
| | | |
| | | |
Entravision Communications Corp. "A" | | | |
| | | |
| | | |
| | | |
| | | |
Integral Ad Science Holding Corp.* | | | |
John Wiley & Sons, Inc. "A" | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
The E.W. Scripps Co. "A"* | | | |
| | | |
Townsquare Media, Inc. "A" | | | |
| | | |
| | | |
| | | |
Wireless Telecommunication Services 0.1% | |
| | | |
| | | |
Telephone & Data Systems, Inc. | | | |
Tingo Group, Inc.* (a) (b) | | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
Consumer Discretionary 10.8% | |
Automobile Components 1.3% | |
| | | |
American Axle & Manufacturing Holdings, Inc.* | | | |
Atmus Filtration Technologies, Inc.* (a) | | | |
Cooper-Standard Holdings, Inc.* | | | |
| | | |
| | | |
Fox Factory Holding Corp.* | | | |
| | | |
Goodyear Tire & Rubber Co.* | | | |
| | | |
| | | |
Luminar Technologies, Inc.* (a) | | | |
Modine Manufacturing Co.* | | | |
| | | |
| | | |
Standard Motor Products, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
Livewire Group, Inc.* (a) | | | |
Winnebago Industries, Inc. | | | |
Workhorse Group, Inc.* (a) | | | |
| | | |
| |
| | | |
| | | |
| | | |
Savers Value Village, Inc.* | | | |
| | | |
| |
| | | |
Diversified Consumer Services 1.2% | |
| | | |
Adtalem Global Education, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
European Wax Center, Inc. "A"* | | | |
| | | |
| | | |
| | |
| | | |
Lincoln Educational Services Corp.* | | | |
| | | |
OneSpaWorld Holdings Ltd.* | | | |
| | | |
| | | |
Strategic Education, Inc. | | | |
| | | |
| | | |
Universal Technical Institute, Inc.* | | | |
| | | |
| | | |
Hotels, Restaurants & Leisure 2.2% | |
Accel Entertainment, Inc.* | | | |
| | | |
Biglari Holdings, Inc. "B"* | | | |
| | | |
| | | |
Bluegreen Vacations Holding Corp. | | | |
| | | |
Brinker International, Inc.* | | | |
Carrols Restaurant Group, Inc. | | | |
| | | |
| | | |
Cracker Barrel Old Country Store, Inc. | | | |
Dave & Buster's Entertainment, Inc.* | | | |
| | | |
| | | |
El Pollo Loco Holdings, Inc.* | | | |
Empire Resorts, Inc.* (b) | | | |
| | | |
First Watch Restaurant Group, Inc.* | | | |
Full House Resorts, Inc.* | | | |
Global Business Travel Group I* | | | |
Golden Entertainment, Inc. | | | |
Hilton Grand Vacations, Inc.* | | | |
Inspired Entertainment, Inc.* | | | |
International Game Technology PLC | | | |
| | | |
| | | |
Kura Sushi USA, Inc. "A"* | | | |
Life Time Group Holdings, Inc.* | | | |
| | | |
Lindblad Expeditions Holdings, Inc.* | | | |
The accompanying notes are an integral part of the financial statements.
| | |
Monarch Casino & Resort, Inc. | | | |
Mondee Holdings, Inc.* (a) | | | |
| | | |
| | | |
Papa John's International, Inc. | | | |
| | | |
| | | |
| | | |
RCI Hospitality Holdings, Inc. | | | |
Red Robin Gourmet Burgers, Inc.* (a) | | | |
Red Rock Resorts, Inc. "A" | | | |
Rush Street Interactive, Inc.* | | | |
| | | |
SeaWorld Entertainment, Inc.* | | | |
| | | |
Six Flags Entertainment Corp.* | | | |
| | | |
| | | |
Target Hospitality Corp.* | | | |
The Cheesecake Factory, Inc. | | | |
The ONE Group Hospitality, Inc.* | | | |
Xponential Fitness, Inc. "A"* | | | |
| | | |
| |
Beazer Homes U.S.A., Inc.* | | | |
| | | |
Century Communities, Inc. | | | |
| | | |
Dream Finders Homes, Inc. "A"* | | | |
Ethan Allen Interiors, Inc. | | | |
| | | |
Green Brick Partners, Inc.* | | | |
| | | |
| | | |
Hovnanian Enterprises, Inc. "A"* | | | |
Installed Building Products, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
Taylor Morrison Home Corp.* | | | |
| | | |
| | | |
United Homes Group, Inc.* (a) | | | |
| | | |
VOXX International Corp.* | | | |
Worthington Enterprises, Inc. | | | |
| | | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Johnson Outdoors, Inc. "A" | | | |
| | | |
| | | |
| | | |
MasterCraft Boat Holdings, Inc.* | | | |
Smith & Wesson Brands, Inc. | | | |
| | | |
| | | |
Topgolf Callaway Brands Corp.* | | | |
| | | |
| | | |
| |
1-800-Flowers.com, Inc. "A"* | | | |
| | | |
Abercrombie & Fitch Co. "A"* | | | |
Academy Sports & Outdoors, Inc. | | | |
American Eagle Outfitters, Inc. | | | |
America's Car-Mart, Inc.* | | | |
| | | |
Asbury Automotive Group, Inc.* | | | |
| | | |
| | | |
Big 5 Sporting Goods Corp. | | | |
Boot Barn Holdings, Inc.* | | | |
Build-a-bear Workshop, Inc. | | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
Camping World Holdings, Inc. "A" | | | |
| | | |
| | | |
| | | |
| | | |
Designer Brands, Inc. "A" | | | |
Destination XL Group, Inc.* | | | |
Duluth Holdings, Inc. "B"* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Haverty Furniture Companies, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
National Vision Holdings, Inc.* | | | |
| | | |
OneWater Marine, Inc. "A"* | | | |
| | | |
Rent the Runway, Inc. "A"* | | | |
| | | |
Sally Beauty Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
Sonic Automotive, Inc. "A" | | | |
Sportsman's Warehouse Holdings, Inc.* | | | |
| | | |
| | | |
The Children's Place, Inc.* | | | |
| | | |
Tile Shop Holdings, Inc.* | | | |
| | | |
Torrid Holdings, Inc.* (a) | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Textiles, Apparel & Luxury Goods 0.5% | |
| | | |
| | | |
| | | |
| | |
G-III Apparel Group Ltd.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Wolverine World Wide, Inc. | | | |
| | | |
| |
| |
Coca-Cola Consolidated, Inc. | | | |
| | | |
| | | |
| | | |
The Duckhorn Portfolio, Inc.* | | | |
| | | |
| | | |
| | | |
Consumer Staples Distribution & Retail 0.6% | |
| | | |
| | | |
Natural Grocers by Vitamin Cottage, Inc. | | | |
| | | |
| | | |
Sprouts Farmers Market, Inc.* | | | |
| | | |
The Chefs' Warehouse, Inc.* | | | |
United Natural Foods, Inc.* | | | |
Village Super Market, Inc. "A" | | | |
| | | |
| | | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Fresh Del Monte Produce, Inc. | | | |
Hain Celestial Group, Inc.* | | | |
| | | |
John B. Sanfilippo & Son, Inc. | | | |
| | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
Central Garden & Pet Co.* | | | |
Central Garden & Pet Co. "A"* | | | |
| | | |
| | | |
| | | |
| | | |
Personal Care Products 0.9% | |
| | | |
Edgewell Personal Care Co. | | | |
| | | |
| | | |
| | | |
| | | |
Nature's Sunshine Products, Inc.* | | | |
Nu Skin Enterprises, Inc. "A" | | | |
| | | |
USANA Health Sciences, Inc.* | | | |
| | | |
| | | |
| |
| | | |
Turning Point Brands, Inc. | | | |
| | | |
| | | |
| | | |
| |
Energy Equipment & Services 2.4% | |
| | | |
Atlas Energy Solutions, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Diamond Offshore Drilling, Inc.* | | | |
| | | |
| | | |
| | | |
| | |
Forum Energy Technologies, Inc.* | | | |
Helix Energy Solutions Group, Inc.* | | | |
| | | |
KLX Energy Services Holdings, Inc.* | | | |
Kodiak Gas Services, Inc. | | | |
| | | |
Mammoth Energy Services, Inc.* | | | |
| | | |
| | | |
| | | |
Oceaneering International, Inc.* | | | |
Oil States International, Inc.* | | | |
Patterson-UTI Energy, Inc. | | | |
ProFrac Holding Corp. "A"* | | | |
| | | |
Ranger Energy Services, Inc. | | | |
| | | |
SEACOR Marine Holdings, Inc.* | | | |
| | | |
Select Water Solutions, Inc. | | | |
Solaris Oilfield Infrastructure, Inc. "A" | | | |
TETRA Technologies, Inc.* | | | |
| | | |
U.S. Silica Holdings, Inc.* | | | |
| | | |
Weatherford International PLC* | | | |
| | | |
Oil, Gas & Consumable Fuels 4.4% | |
| | | |
| | | |
| | | |
California Resources Corp. | | | |
| | | |
Centrus Energy Corp. "A"* | | | |
| | | |
| | | |
Clean Energy Fuels Corp.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Delek U.S. Holdings, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
Equitrans Midstream Corp. | | | |
Evolution Petroleum Corp. | | | |
Excelerate Energy, Inc. "A" | | | |
| | | |
| | | |
| | | |
| | | |
Granite Ridge Resources, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
International Seaways, Inc. | | | |
| | | |
| | | |
Magnolia Oil & Gas Corp. "A" | | | |
| | | |
| | | |
NACCO Industries, Inc. "A" | | | |
| | | |
Nordic American Tankers Ltd. | | | |
Northern Oil and Gas, Inc. | | | |
Overseas Shipholding Group, Inc. "A" | | | |
Par Pacific Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
PrimeEnergy Resources Corp.* | | | |
REX American Resources Corp.* | | | |
Riley Exploration Permian, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
SilverBow Resources, Inc.* | | | |
Sitio Royalties Corp. "A" | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Uranium Energy Corp.* (a) | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| | | |
| | | |
| | | |
| |
| |
| | | |
| | | |
Amalgamated Financial Corp. | | | |
| | | |
American National Bankshares, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
Atlantic Union Bankshares Corp. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Bank of NT Butterfield & Son Ltd. | | | |
| | | |
| | | |
Bankwell Financial Group, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
Berkshire Hills Bancorp., Inc. | | | |
| | | |
Blue Ridge Bankshares, Inc. | | | |
Bridgewater Bancshares, Inc.* | | | |
| | | |
Burke & Herbert Financial Services Corp. | | | |
Business First Bancshares, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Capital City Bank Group, Inc. | | | |
Capitol Federal Financial, Inc. | | | |
Capstar Financial Holdings, Inc. | | | |
| | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
Central Pacific Financial Corp. | | | |
Central Valley Community Bancorp. | | | |
| | | |
ChoiceOne Financial Services, Inc. (a) | | | |
Citizens & Northern Corp. | | | |
Citizens Financial Services, Inc. (a) | | | |
| | | |
| | | |
| | | |
| | | |
Codorus Valley Bancorp., Inc. | | | |
| | | |
Columbia Financial, Inc.* | | | |
Community Bank System, Inc. | | | |
Community Trust Bancorp., Inc. | | | |
ConnectOne Bancorp., Inc. | | | |
CrossFirst Bankshares, Inc.* | | | |
Customers Bancorp., Inc.* | | | |
| | | |
Dime Community Bancshares, Inc. | | | |
| | | |
| | | |
Enterprise Bancorp., Inc. | | | |
Enterprise Financial Services Corp. | | | |
Equity Bancshares, Inc. "A" | | | |
Esquire Financial Holdings, Inc. | | | |
| | | |
| | | |
Farmers & Merchants Bancorp., Inc. | | | |
Farmers National Banc Corp. (a) | | | |
| | | |
Fidelity D&D Bancorp, Inc. | | | |
Financial Institutions, Inc. | | | |
| | | |
First BanCorp. - North Carolina | | | |
| | | |
| | | |
| | | |
| | | |
First Business Financial Services, Inc. | | | |
First Commonwealth Financial Corp. | | | |
First Community Bancshares, Inc. | | | |
| | | |
| | |
| | | |
First Financial Bankshares, Inc. | | | |
| | | |
| | | |
First Interstate BancSystem, Inc. "A" | | | |
| | | |
First Mid Bancshares, Inc. | | | |
First of Long Island Corp. | | | |
First Western Financial, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
German American Bancorp., Inc. | | | |
| | | |
Great Southern Bancorp., Inc. | | | |
Greene County Bancorp., Inc. | | | |
Guaranty Bancshares, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
Heartland Financial U.S.A., Inc. | | | |
| | | |
| | | |
| | | |
Hingham Institution For Savings (a) | | | |
| | | |
| | | |
| | | |
HomeTrust Bancshares, Inc. | | | |
| | | |
| | | |
| | | |
Independent Bank Group, Inc. | | | |
International Bancshares Corp. | | | |
John Marshall Bancorp, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
Live Oak Bancshares, Inc. | | | |
| | | |
| | | |
MainStreet Bancshares, Inc. | | | |
| | | |
Metrocity Bankshares, Inc. | | | |
The accompanying notes are an integral part of the financial statements.
| | |
Metropolitan Bank Holding Corp.* | | | |
| | | |
| | | |
Midland States Bancorp., Inc. | | | |
MidWestOne Financial Group, Inc. | | | |
| | | |
National Bank Holdings Corp. "A" | | | |
National Bankshares, Inc. | | | |
| | | |
| | | |
| | | |
Northeast Community Bancorp, Inc. | | | |
Northfield Bancorp., Inc. | | | |
| | | |
Northwest Bancshares, Inc. | | | |
| | | |
| | | |
OceanFirst Financial Corp. | | | |
| | | |
| | | |
Old Second Bancorp., Inc. | | | |
Orange County Bancorp, Inc. | | | |
| | | |
Orrstown Financial Services, Inc. | | | |
Pacific Premier Bancorp., Inc. | | | |
| | | |
| | | |
| | | |
| | | |
Peapack-Gladstone Financial Corp. | | | |
Penns Woods Bancorp., Inc. | | | |
| | | |
Peoples Financial Services Corp. | | | |
| | | |
| | | |
Ponce Financial Group, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
Provident Financial Services, Inc. | | | |
| | | |
| | | |
Red River Bancshares, Inc. | | | |
| | | |
Republic Bancorp., Inc. "A" | | | |
| | | |
| | |
Sandy Spring Bancorp., Inc. | | | |
Seacoast Banking Corp. of Florida | | | |
ServisFirst Bancshares, Inc. | | | |
| | | |
| | | |
Simmons First National Corp. "A" | | | |
| | | |
South Plains Financial, Inc. | | | |
Southern First Bancshares, Inc.* | | | |
Southern Missouri Bancorp., Inc. | | | |
Southern States Bancshares, Inc. | | | |
Southside Bancshares, Inc. | | | |
| | | |
| | | |
| | | |
Stock Yards Bancorp., Inc. | | | |
Summit Financial Group, Inc. | | | |
Texas Capital Bancshares, Inc.* | | | |
| | | |
Third Coast Bancshares, Inc.* | | | |
Timberland Bancorp., Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
United Community Banks, Inc. | | | |
| | | |
| | | |
USCB Financial Holdings, Inc.* | | | |
| | | |
| | | |
Virginia National Bankshares Corp. | | | |
| | | |
Washington Trust Bancorp., Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
Artisan Partners Asset Management, Inc. "A" | | | |
AssetMark Financial Holdings, Inc.* | | | |
B. Riley Financial, Inc. (a) | | | |
Bakkt Holdings, Inc.* (a) | | | |
| | | |
Brightsphere Investment Group, Inc. | | | |
| | | |
Diamond Hill Investment Group, Inc. | | | |
Donnelley Financial Solutions, Inc.* | | | |
Forge Global Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Patria Investments Ltd. "A" | | | |
Perella Weinberg Partners | | | |
| | | |
| | | |
Silvercrest Asset Management Group, Inc. "A" | | | |
StepStone Group, Inc. "A" | | | |
| | | |
| | | |
Victory Capital Holdings, Inc. "A" | | | |
Virtus Investment Partners, Inc. | | | |
| | | |
| | | |
| |
Atlanticus Holdings Corp.* | | | |
Bread Financial Holdings, Inc. | | | |
Consumer Portfolio Services, Inc.* | | | |
Encore Capital Group, Inc.* | | | |
Enova International, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Regional Management Corp. | | | |
| | |
Upstart Holdings, Inc.* (a) | | | |
| | | |
| | | |
| |
| | | |
| | | |
A-Mark Precious Metals, Inc. | | | |
AvidXchange Holdings, Inc.* | | | |
Banco Latinoamericano de Comercio Exterior SA | | | |
| | | |
| | | |
Cass Information Systems, Inc. | | | |
Compass Diversified Holdings | | | |
| | | |
| | | |
| | | |
Federal Agricultural Mortgage Corp. "C" | | | |
Finance of America Companies, Inc. "A"* | | | |
| | | |
| | | |
International Money Express, Inc.* | | | |
Jackson Financial, Inc. "A" | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Pagseguro Digital Ltd. "A"* | | | |
| | | |
| | | |
| | | |
PennyMac Financial Services, Inc. | | | |
Priority Technology Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
Security National Financial Corp. "A"* | | | |
| | | |
| | | |
Velocity Financial, Inc.* | | | |
| | | |
Waterstone Financial, Inc. | | | |
| | | |
| |
Ambac Financial Group, Inc.* | | | |
The accompanying notes are an integral part of the financial statements.
| | |
American Coastal Insurance Corp. "C"* | | | |
American Equity Investment Life Holding Co.* | | | |
| | | |
| | | |
CNO Financial Group, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
F&G Annuities & Life, Inc. | | | |
Fidelis Insurance Holdings Ltd.* | | | |
Genworth Financial, Inc. "A"* | | | |
| | | |
Goosehead Insurance, Inc. "A"* | | | |
Greenlight Capital Re Ltd. "A"* | | | |
| | | |
| | | |
Horace Mann Educators Corp. | | | |
| | | |
James River Group Holdings Ltd. | | | |
Kingsway Financial Services, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
National Western Life Group, Inc. "A" | | | |
| | | |
| | | |
| | | |
| | | |
Safety Insurance Group, Inc. | | | |
Selective Insurance Group, Inc. | | | |
| | | |
| | | |
Skyward Specialty Insurance Group, Inc.* | | | |
Stewart Information Services Corp. | | | |
| | | |
| | | |
| | | |
Universal Insurance Holdings, Inc. | | | |
| | | |
| | |
Mortgage Real Estate Investment Trusts (REITs) 1.2% | |
| | | |
Angel Oak Mortgage REIT, Inc. | | | |
Apollo Commercial Real Estate Finance, Inc. | | | |
Arbor Realty Trust, Inc. (a) | | | |
Ares Commercial Real Estate Corp. | | | |
ARMOUR Residential REIT, Inc. (a) | | | |
Blackstone Mortgage Trust, Inc. "A" (a) | | | |
BrightSpire Capital, Inc. | | | |
Chicago Atlantic Real Estate Finance, Inc. | | | |
| | | |
Claros Mortgage Trust, Inc. | | | |
| | | |
Ellington Financial, Inc. | | | |
Franklin BSP Realty Trust, Inc. | | | |
Granite Point Mortgage Trust, Inc. | | | |
Hannon Armstrong Sustainable Infrastructure Capital, Inc. (a) | | | |
Invesco Mortgage Capital, Inc. | | | |
KKR Real Estate Finance Trust, Inc. | | | |
| | | |
| | | |
New York Mortgage Trust, Inc. | | | |
Nexpoint Real Estate Finance, Inc. | | | |
Orchid Island Capital, Inc. | | | |
PennyMac Mortgage Investment Trust | | | |
| | | |
| | | |
TPG RE Finance Trust, Inc. | | | |
Two Harbors Investment Corp. | | | |
| | | |
| |
| |
| | | |
4D Molecular Therapeutics, Inc.* | | | |
| | | |
| | | |
ACADIA Pharmaceuticals, Inc.* | | | |
| | | |
Acrivon Therapeutics, Inc.* | | | |
The accompanying notes are an integral part of the financial statements.
| | |
Actinium Pharmaceuticals, Inc.* | | | |
| | | |
| | | |
Aerovate Therapeutics, Inc.* | | | |
| | | |
Agios Pharmaceuticals, Inc.* | | | |
Akero Therapeutics, Inc.* | | | |
Aldeyra Therapeutics, Inc.* | | | |
| | | |
| | | |
| | | |
Allogene Therapeutics, Inc.* | | | |
| | | |
Alpine Immune Sciences, Inc.* (a) | | | |
| | | |
ALX Oncology Holdings, Inc.* (a) | | | |
Amicus Therapeutics, Inc.* | | | |
| | | |
Anavex Life Sciences Corp.* (a) | | | |
Anika Therapeutics, Inc.* | | | |
| | | |
Apogee Therapeutics, Inc.* (a) | | | |
| | | |
| | | |
Arcturus Therapeutics Holdings, Inc.* | | | |
| | | |
Arcutis Biotherapeutics, Inc.* | | | |
| | | |
Arrowhead Pharmaceuticals, Inc.* | | | |
ARS Pharmaceuticals, Inc.* | | | |
Astria Therapeutics, Inc.* | | | |
Atara Biotherapeutics, Inc.* | | | |
| | | |
Aurinia Pharmaceuticals, Inc.* | | | |
| | | |
Avidity Biosciences, Inc.* | | | |
| | | |
| | | |
| | | |
BioCryst Pharmaceuticals, Inc.* | | | |
| | | |
| | | |
| | | |
Bioxcel Therapeutics, Inc.* (a) | | | |
| | | |
Blueprint Medicines Corp.* | | | |
| | |
| | | |
| | | |
| | | |
Caribou Biosciences, Inc.* | | | |
Carisma Therapeutics, Inc. | | | |
Cartesian Therapeutics, Inc.* | | | |
Catalyst Pharmaceuticals, Inc.* | | | |
| | | |
Celldex Therapeutics, Inc.* | | | |
Century Therapeutics, Inc.* | | | |
Cerevel Therapeutics Holdings, Inc.* | | | |
Cogent Biosciences, Inc.* | | | |
Coherus Biosciences, Inc.* | | | |
Compass Therapeutics, Inc.* | | | |
Crinetics Pharmaceuticals, Inc.* | | | |
| | | |
| | | |
| | | |
Day One Biopharmaceuticals, Inc.* | | | |
Deciphera Pharmaceuticals, Inc.* | | | |
Denali Therapeutics, Inc.* | | | |
Design Therapeutics, Inc.* | | | |
| | | |
Dynavax Technologies Corp.* | | | |
| | | |
Eagle Pharmaceuticals, Inc.* | | | |
| | | |
Emergent BioSolutions, Inc.* | | | |
Enanta Pharmaceuticals, Inc.* | | | |
Entrada Therapeutics, Inc.* | | | |
| | | |
| | | |
Fennec Pharmaceuticals, Inc.* | | | |
| | | |
Foghorn Therapeutics, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Halozyme Therapeutics, Inc.* | | | |
Heron Therapeutics, Inc.* | | | |
| | | |
| | | |
| | | |
Ideaya Biosciences, Inc.* | | | |
| | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Intellia Therapeutics, Inc.* | | | |
Iovance Biotherapeutics, Inc.* | | | |
Ironwood Pharmaceuticals, Inc.* | | | |
iTeos Therapeutics, Inc.* | | | |
Janux Therapeutics, Inc.* | | | |
KalVista Pharmaceuticals, Inc.* | | | |
Karyopharm Therapeutics, Inc.* | | | |
Keros Therapeutics, Inc.* | | | |
Kezar Life Sciences, Inc.* | | | |
Kiniksa Pharmaceuticals Ltd. "A"* | | | |
| | | |
| | | |
| | | |
Kymera Therapeutics, Inc.* | | | |
Larimar Therapeutics, Inc.* | | | |
Lexicon Pharmaceuticals, Inc.* | | | |
Lineage Cell Therapeutics, Inc.* | | | |
Lyell Immunopharma, Inc.* | | | |
| | | |
Madrigal Pharmaceuticals, Inc.* | | | |
| | | |
| | | |
Merrimack Pharmaceuticals, Inc.* | | | |
Mersana Therapeutics, Inc.* | | | |
| | | |
Mineralys Therapeutics, Inc.* | | | |
Mirum Pharmaceuticals, Inc.* | | | |
Monte Rosa Therapeutics, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Nurix Therapeutics, Inc.* | | | |
| | | |
| | | |
| | | |
Olema Pharmaceuticals, Inc.* | | | |
Omega Therapeutics, Inc.* | | | |
| | |
Organogenesis Holdings, Inc.* | | | |
ORIC Pharmaceuticals, Inc.* | | | |
Outlook Therapeutics, Inc.* (a) | | | |
| | | |
PDS Biotechnology Corp.* (a) | | | |
| | | |
PMV Pharmaceuticals, Inc.* | | | |
Poseida Therapeutics, Inc.* | | | |
| | | |
Prelude Therapeutics, Inc.* | | | |
Prime Medicine, Inc.* (a) | | | |
| | | |
Protagonist Therapeutics, Inc.* | | | |
Protalix BioTherapeutics, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Recursion Pharmaceuticals, Inc. "A"* | | | |
| | | |
Relay Therapeutics, Inc.* | | | |
Reneo Pharmaceuticals, Inc.* | | | |
| | | |
REVOLUTION Medicines, Inc.* | | | |
Rhythm Pharmaceuticals, Inc.* | | | |
Rigel Pharmaceuticals, Inc.* | | | |
Rocket Pharmaceuticals, Inc.* | | | |
| | | |
Sagimet Biosciences, Inc. "A"* | | | |
Sana Biotechnology, Inc.* | | | |
Sangamo Therapeutics, Inc.* | | | |
| | | |
Scholar Rock Holding Corp.* | | | |
Seres Therapeutics, Inc.* | | | |
SpringWorks Therapeutics, Inc.* | | | |
Stoke Therapeutics, Inc.* | | | |
Summit Therapeutics, Inc.* | | | |
| | | |
Syndax Pharmaceuticals, Inc.* | | | |
Tango Therapeutics, Inc.* | | | |
Tenaya Therapeutics, Inc.* | | | |
| | | |
Travere Therapeutics, Inc.* | | | |
Turnstone Biologics Corp.* | | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
| | | |
| | | |
Vanda Pharmaceuticals, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Verve Therapeutics, Inc.* | | | |
Vigil Neuroscience, Inc.* | | | |
Viking Therapeutics, Inc.* | | | |
| | | |
Viridian Therapeutics, Inc.* | | | |
| | | |
Voyager Therapeutics, Inc.* | | | |
X4 Pharmaceuticals, Inc.* | | | |
| | | |
| | | |
Y-mAbs Therapeutics, Inc.* | | | |
Zentalis Pharmaceuticals, Inc.* | | | |
| | | |
| | | |
| | | |
Health Care Equipment & Supplies 2.8% | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
iRhythm Technologies, Inc.* | | | |
KORU Medical Systems, Inc.* | | | |
| | | |
| | |
| | | |
| | | |
Merit Medical Systems, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
OraSure Technologies, Inc.* | | | |
Orchestra BioMed Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
PROCEPT BioRobotics Corp.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Tactile Systems Technology, Inc.* | | | |
| | | |
| | | |
Treace Medical Concepts, Inc.* | | | |
| | | |
Utah Medical Products, Inc. | | | |
| | | |
Vicarious Surgical, Inc.* | | | |
| | | |
| | | |
| | | |
Health Care Providers & Services 2.4% | |
| | | |
| | | |
| | | |
| | | |
| | | |
AirSculpt Technologies, Inc.* | | | |
Alignment Healthcare, Inc.* | | | |
AMN Healthcare Services, Inc.* | | | |
Apollo Medical Holdings, Inc.* | | | |
Aveanna Healthcare Holdings, Inc.* | | | |
Brookdale Senior Living, Inc.* | | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
Castle Biosciences, Inc.* | | | |
Community Health Systems, Inc.* | | | |
| | | |
Cross Country Healthcare, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Hims & Hers Health, Inc.* | | | |
InfuSystem Holdings, Inc.* | | | |
| | | |
| | | |
LifeStance Health Group, Inc.* (a) | | | |
| | | |
National HealthCare Corp. | | | |
| | | |
| | | |
| | | |
Option Care Health, Inc.* | | | |
| | | |
P3 Health Partners, Inc.* | | | |
Patterson Companies, Inc. | | | |
Pediatrix Medical Group, Inc.* | | | |
| | | |
Privia Health Group, Inc.* | | | |
| | | |
Quipt Home Medical Corp.* | | | |
| | | |
Select Medical Holdings Corp. | | | |
| | | |
| | | |
| | | |
| | | |
U.S. Physical Therapy, Inc. | | | |
| | | |
| | | |
Health Care Technology 0.5% | |
| | | |
Computer Programs & Systems, Inc.* | | | |
Definitive Healthcare Corp.* | | | |
Evolent Health, Inc. "A"* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| | | |
| | | |
| | | |
Life Sciences Tools & Services 0.4% | |
Adaptive Biotechnologies Corp.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Harvard Bioscience, Inc.* | | | |
| | | |
| | | |
NanoString Technologies, Inc.* | | | |
Nautilus Biotechnology, Inc.* | | | |
| | | |
Pacific Biosciences of California, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
Aclaris Therapeutics, Inc.* | | | |
Amneal Pharmaceuticals, Inc.* | | | |
Amphastar Pharmaceuticals, Inc.* | | | |
Amylyx Pharmaceuticals, Inc.* | | | |
ANI Pharmaceuticals, Inc.* | | | |
| | | |
| | | |
Atea Pharmaceuticals, Inc.* | | | |
Axsome Therapeutics, Inc.* | | | |
| | | |
| | | |
| | | |
Cassava Sciences, Inc.* (a) | | | |
Citius Pharmaceuticals, Inc.* | | | |
Collegium Pharmaceutical, Inc.* | | | |
Corcept Therapeutics, Inc.* | | | |
| | | |
Cymabay Therapeutics, Inc.* | | | |
Edgewise Therapeutics, Inc.* | | | |
Enliven Therapeutics, Inc.* (a) | | | |
| | | |
| | | |
EyePoint Pharmaceuticals, Inc.* | | | |
The accompanying notes are an integral part of the financial statements.
| | |
Harmony Biosciences Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
Intra-Cellular Therapies, Inc.* | | | |
Ligand Pharmaceuticals, Inc.* | | | |
| | | |
Longboard Pharmaceuticals, Inc.* | | | |
Marinus Pharmaceuticals, Inc.* | | | |
Neumora Therapeutics, Inc.* | | | |
NGM Biopharmaceuticals, Inc.* | | | |
| | | |
Ocular Therapeutix, Inc.* | | | |
| | | |
| | | |
Pacira BioSciences, Inc.* | | | |
Phathom Pharmaceuticals, Inc.* | | | |
Phibro Animal Health Corp. "A" | | | |
Pliant Therapeutics, Inc.* | | | |
Prestige Consumer Healthcare, Inc.* | | | |
Revance Therapeutics, Inc.* | | | |
| | | |
| | | |
| | | |
Supernus Pharmaceuticals, Inc.* | | | |
Taro Pharmaceutical Industries Ltd.* | | | |
Tarsus Pharmaceuticals, Inc.* | | | |
Terns Pharmaceuticals, Inc.* | | | |
Theravance Biopharma, Inc.* (a) | | | |
Theseus Pharmaceuticals, Inc.* | | | |
Third Harmonic Bio, Inc.* | | | |
Trevi Therapeutics, Inc.* | | | |
Ventyx Biosciences, Inc.* | | | |
Verrica Pharmaceuticals, Inc.* | | | |
| | | |
Xeris Biopharma Holdings, Inc.* | | | |
Zevra Therapeutics, Inc.* | | | |
| | | |
| |
| |
| | | |
| | | |
| | |
| | | |
Archer Aviation, Inc. "A"* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Kratos Defense & Security Solutions, Inc.* | | | |
| | | |
| | | |
National Presto Industries, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Virgin Galactic Holdings, Inc.* | | | |
| | | |
Air Freight & Logistics 0.2% | |
Air Transport Services Group, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
Gibraltar Industries, Inc.* | | | |
| | | |
| | | |
Janus International Group, Inc.* | | | |
| | | |
Masonite International Corp.* | | | |
| | | |
| | | |
Quanex Building Products Corp. | | | |
Resideo Technologies, Inc.* | | | |
Simpson Manufacturing Co., Inc. | | | |
| | | |
Zurn Elkay Water Solutions Corp. | | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
Commercial Services & Supplies 1.5% | |
| | | |
| | | |
| | | |
Aris Water Solutions, Inc. "A" | | | |
BrightView Holdings, Inc.* | | | |
Casella Waste Systems, Inc. "A"* | | | |
CECO Environmental Corp.* | | | |
| | | |
CompX International, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
Healthcare Services Group, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
Liquidity Services, Inc.* | | | |
Matthews International Corp. "A" | | | |
| | | |
Montrose Environmental Group, Inc.* | | | |
| | | |
| | | |
Performant Financial Corp.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Construction & Engineering 1.7% | |
| | | |
| | | |
| | | |
| | | |
Bowman Consulting Group Ltd.* | | | |
Comfort Systems U.S.A., Inc. | | | |
Concrete Pumping Holdings, Inc.* | | | |
Construction Partners, Inc. "A"* | | | |
| | | |
| | | |
Granite Construction, Inc. | | | |
| | |
Great Lakes Dredge & Dock Corp.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Southland Holdings, Inc.* | | | |
Sterling Infrastructure, Inc.* | | | |
| | | |
| | | |
Electrical Equipment 1.3% | |
| | | |
Amprius Technologies, Inc.* | | | |
Array Technologies, Inc.* | | | |
| | | |
Babcock & Wilcox Enterprises, Inc.* | | | |
| | | |
Bloom Energy Corp. "A"* (a) | | | |
Dragonfly Energy Holdings Corp.* | | | |
| | | |
Energy Vault Holdings, Inc.* | | | |
| | | |
| | | |
Eos Energy Enterprises, Inc.* (a) | | | |
| | | |
| | | |
| | | |
| | | |
GrafTech International, Ltd. | | | |
| | | |
| | | |
| | | |
| | | |
Preformed Line Products Co. | | | |
| | | |
Shoals Technologies Group, Inc. "A"* | | | |
| | | |
| | | |
| | | |
Thermon Group Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
Ground Transportation 0.5% | |
| | | |
Covenant Logistics Group, Inc. | | | |
| | | |
FTAI Infrastructure, Inc. | | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
| | | |
P.A.M. Transportation Services, Inc.* | | | |
| | | |
TuSimple Holdings, Inc. "A"* | | | |
Universal Logistics Holdings, Inc. | | | |
| | | |
| | | |
Industrial Conglomerates 0.0% | |
Brookfield Business Corp. "A" | | | |
| |
| | | |
| | | |
| | | |
Albany International Corp. "A" | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Commercial Vehicle Group, Inc.* | | | |
Desktop Metal, Inc. "A"* (a) | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Franklin Electric Co., Inc. | | | |
| | | |
| | | |
Greenbrier Companies, Inc. | | | |
Helios Technologies, Inc. | | | |
| | | |
| | | |
| | | |
Hyster-Yale Materials Handling, Inc. | | | |
John Bean Technologies Corp. | | | |
| | | |
| | | |
| | | |
| | | |
Mayville Engineering Co., Inc.* | | | |
Microvast Holdings, Inc.* | | | |
| | | |
| | | |
Mueller Water Products, Inc. "A" | | | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Standex International Corp. | | | |
| | | |
| | | |
| | | |
Titan International, Inc.* | | | |
| | | |
| | | |
| | | |
Watts Water Technologies, Inc. "A" | | | |
| | | |
Marine Transportation 0.3% | |
| | | |
Eagle Bulk Shipping, Inc. | | | |
Genco Shipping & Trading Ltd. | | | |
| | | |
| | | |
| | | |
Pangaea Logistics Solutions Ltd. | | | |
| | | |
| | | |
| |
| | | |
Blade Air Mobility, Inc.* | | | |
Frontier Group Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Sun Country Airlines Holdings, Inc.* | | | |
| | | |
Professional Services 2.5% | |
| | | |
| | | |
| | | |
Barrett Business Services, Inc. | | | |
Blacksky Technology, Inc.* | | | |
| | | |
| | | |
| | | |
CSG Systems International, Inc. | | | |
The accompanying notes are an integral part of the financial statements.
| | |
ExlService Holdings, Inc.* | | | |
| | | |
| | | |
FiscalNote Holdings, Inc.* | | | |
Forrester Research, Inc.* | | | |
| | | |
Heidrick & Struggles International, Inc. | | | |
| | | |
HireRight Holdings Corp.* | | | |
Huron Consulting Group, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Resources Connection, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Trading Companies & Distributors 2.0% | |
Alta Equipment Group, Inc. | | | |
Applied Industrial Technologies, Inc. | | | |
Beacon Roofing Supply, Inc.* | | | |
| | | |
| | | |
Custom Truck One Source, Inc.* | | | |
Distribution Solutions Group, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
H&E Equipment Services, Inc. | | | |
| | | |
| | |
Hudson Technologies, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
Rush Enterprises, Inc. "A" | | | |
Rush Enterprises, Inc. "B" | | | |
Textainer Group Holdings Ltd. | | | |
| | | |
| | | |
Willis Lease Finance Corp.* | | | |
| | | |
| | | |
Information Technology 13.3% | |
Communications Equipment 0.6% | |
| | | |
| | | |
| | | |
| | | |
| | | |
CommScope Holding Co., Inc.* | | | |
Comtech Telecommunications Corp. | | | |
Digi International, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Ribbon Communications, Inc.* | | | |
| | | |
| | | |
Electronic Equipment, Instruments & Components 2.7% | |
| | | |
Advanced Energy Industries, Inc. | | | |
| | | |
Akoustis Technologies, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
Benchmark Electronics, Inc. | | | |
Climb Global Solutions, Inc. | | | |
| | | |
| | | |
| | | |
Evolv Technologies Holdings, Inc.* | | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
| | | |
Insight Enterprises, Inc.* | | | |
| | | |
| | | |
Kimball Electronics, Inc.* | | | |
| | | |
Lightwave Logic, Inc.* (a) | | | |
| | | |
Methode Electronics, Inc. | | | |
| | | |
Mirion Technologies, Inc.* | | | |
Napco Security Technologies, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Richardson Electronics Ltd. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Vishay Intertechnology, Inc. | | | |
Vishay Precision Group, Inc.* | | | |
| | | |
| | | |
| |
| | | |
BigBear.ai Holdings, Inc.* | | | |
BigCommerce Holdings, Inc.Series 1* | | | |
| | | |
| | | |
DigitalOcean Holdings, Inc.* | | | |
| | | |
Grid Dynamics Holdings, Inc.* | | | |
Information Services Group, Inc. | | | |
| | | |
Rackspace Technology, Inc.* | | | |
| | | |
| | | |
Thoughtworks Holding, Inc.* | | | |
| | | |
| | | |
| | | |
| | |
Semiconductors & Semiconductor Equipment 3.0% | |
| | | |
| | | |
Alpha & Omega Semiconductor Ltd.* | | | |
| | | |
| | | |
| | | |
Axcelis Technologies, Inc.* | | | |
| | | |
| | | |
Credo Technology Group Holding Ltd.* | | | |
| | | |
| | | |
| | | |
| | | |
indie Semiconductor, Inc. "A"* | | | |
| | | |
Kulicke & Soffa Industries, Inc. | | | |
MACOM Technology Solutions Holdings, Inc.* | | | |
Maxeon Solar Technologies Ltd.* | | | |
| | | |
Navitas Semiconductor Corp.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Silicon Laboratories, Inc.* | | | |
| | | |
SkyWater Technology, Inc.* | | | |
SMART Global Holdings, Inc.* | | | |
| | | |
| | | |
Ultra Clean Holdings, Inc.* | | | |
| | | |
| | | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
Alarm.com Holdings, Inc.* | | | |
| | | |
Altair Engineering, Inc. "A"* | | | |
The accompanying notes are an integral part of the financial statements.
| | |
American Software, Inc. "A" | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Consensus Cloud Solutions, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
E2open Parent Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Instructure Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Marathon Digital Holdings, Inc.* (a) | | | |
| | | |
| | | |
MicroStrategy, Inc. "A"* (a) | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
PowerSchool Holdings, Inc. "A"* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Riot Platforms, Inc.* (a) | | | |
Sapiens International Corp. NV | | | |
SEMrush Holdings, Inc. "A"* | | | |
| | | |
SoundHound AI, Inc. "A"* (a) | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Viant Technology, Inc. "A"* | | | |
Weave Communications, Inc.* | | | |
| | | |
| | | |
| | | |
Zeta Global Holdings Corp. "A"* | | | |
| | | |
| | | |
Technology Hardware, Storage & Peripherals 0.7% | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Super Micro Computer, Inc.* | | | |
| | | |
| | | |
| | | |
| |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
Core Molding Technologies, Inc.* | | | |
Danimer Scientific, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Minerals Technologies, Inc. | | | |
| | | |
| | | |
| | | |
PureCycle Technologies, Inc.* (a) | | | |
| | | |
Rayonier Advanced Materials, Inc.* | | | |
Sensient Technologies Corp. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Construction Materials 0.3% | |
| | | |
Summit Materials, Inc. "A"* | | | |
United States Lime & Minerals, Inc. | | | |
| | | |
Containers & Packaging 0.3% | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
5E Advanced Materials, Inc.* | | | |
Alpha Metallurgical Resources, Inc. | | | |
| | | |
| | | |
Caledonia Mining Corp. PLC | | | |
Carpenter Technology Corp. | | | |
| | | |
| | | |
| | |
| | | |
Compass Minerals International, Inc. | | | |
| | | |
| | | |
| | | |
Haynes International, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
NioCorp. Developments Ltd.* | | | |
Novagold Resources, Inc.* | | | |
| | | |
Perpetua Resources Corp.* | | | |
| | | |
Ramaco Resources, Inc. "A" | | | |
Ramaco Resources, Inc. "B" | | | |
| | | |
Schnitzer Steel Industries, Inc. "A" | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Paper & Forest Products 0.1% | |
| | | |
| | | |
| | | |
| | | |
| |
| |
Alexander & Baldwin, Inc. | | | |
Alpine Income Property Trust, Inc. | | | |
American Assets Trust, Inc. | | | |
Armada Hoffler Properties, Inc. | | | |
Broadstone Net Lease, Inc. | | | |
| | | |
Empire State Realty Trust, Inc. "A" | | | |
Essential Properties Realty Trust, Inc. | | | |
Gladstone Commercial Corp. | | | |
| | | |
NexPoint Diversified Real Estate Trust | | | |
One Liberty Properties, Inc. | | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
| |
| | | |
Community Healthcare Trust, Inc. | | | |
Diversified Healthcare Trust | | | |
Global Medical REIT, Inc. | | | |
| | | |
National Health Investors, Inc. | | | |
| | | |
Sabra Health Care REIT, Inc. | | | |
Universal Health Realty Income Trust | | | |
| | | |
Hotel & Resort REITs 0.8% | |
Apple Hospitality REIT, Inc. | | | |
Braemar Hotels & Resorts, Inc. | | | |
| | | |
DiamondRock Hospitality Co. | | | |
| | | |
| | | |
Ryman Hospitality Properties, Inc. | | | |
| | | |
Summit Hotel Properties, Inc. | | | |
Sunstone Hotel Investors, Inc. | | | |
Xenia Hotels & Resorts, Inc. | | | |
| | | |
| |
Innovative Industrial Properties, Inc. | | | |
| | | |
Plymouth Industrial REIT, Inc. | | | |
| | | |
| | | |
| |
| | | |
| | | |
| | | |
| | | |
Easterly Government Properties, Inc. | | | |
| | | |
Hudson Pacific Properties, Inc. | | | |
| | | |
Office Properties Income Trust | | | |
| | | |
| | | |
Peakstone Realty Trust (a) | | | |
| | |
Piedmont Office Realty Trust, Inc. "A" | | | |
Postal Realty Trust, Inc. "A" | | | |
SL Green Realty Corp. (a) | | | |
| | | |
Real Estate Management & Development 0.8% | |
American Realty Investors, Inc.* | | | |
Anywhere Real Estate, Inc.* | | | |
| | | |
| | | |
DigitalBridge Group, Inc. | | | |
| | | |
eXp World Holdings, Inc. (a) | | | |
| | | |
| | | |
Kennedy-Wilson Holdings, Inc. | | | |
| | | |
Maui Land & Pineapple Co., Inc.* | | | |
| | | |
Opendoor Technologies, Inc.* | | | |
RE/MAX Holdings, Inc. "A" | | | |
| | | |
| | | |
Stratus Properties, Inc.* | | | |
| | | |
| | | |
| | | |
Transcontinental Realty Investors, Inc.* | | | |
| | | |
| |
Apartment Investment and Management Co. "A" * | | | |
| | | |
| | | |
| | | |
| | | |
Independence Realty Trust, Inc. | | | |
NexPoint Residential Trust, Inc. | | | |
| | | |
| | | |
| | | |
| |
| | | |
| | | |
Cbl & Associates Properties, Inc. | | | |
| | | |
Inventrust Properties Corp. | | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
| | | |
Phillips Edison & Co., Inc. | | | |
Retail Opportunity Investments Corp. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
Four Corners Property Trust, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
Portland General Electric Co. | | | |
| | | |
| |
Brookfield Infrastructure Corp. "A" | | | |
Chesapeake Utilities Corp. | | | |
New Jersey Resources Corp. | | | |
Northwest Natural Holding Co. | | | |
| | | |
| | | |
Southwest Gas Holdings, Inc. | | | |
| | | |
| | | |
Independent Power & Renewable Electricity Producers 0.3% | |
| | | |
Montauk Renewables, Inc.* | | | |
| | | |
Sunnova Energy International, Inc.* (a) | | | |
| | | |
| | |
| |
| | | |
| | | |
Northwestern Energy Group, Inc. | | | |
| | | |
| | | |
| |
American States Water Co. | | | |
Artesian Resources Corp. "A" | | | |
| | | |
California Water Service Group | | | |
Consolidated Water Co., Ltd. | | | |
Global Water Resources, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Total Common Stocks (Cost $337,832,927) | |
| |
| |
Life Sciences Tools & Services 0.0% | |
OmniAb, Inc. $12.50 Earnout* (b) (c) | | | |
OmniAb, Inc. $15.00 Earnout* (b) (c) | | | |
Total Other Investments (Cost $0) | |
| |
| |
| | | |
Cartesian Therapeutics, Inc.* (b) | | | |
Chinook Therapeutics, Inc.* (b) | | | |
| | | |
Tobira Therapeutics, Inc.* (b) | | | |
Total Rights (Cost $6,527) | | | |
| |
| |
Cassava Sciences, Inc., Expiration Date 11/15/2024* (b) (Cost $0) | | | |
The accompanying notes are an integral part of the financial statements.
| | |
Government & Agency Obligations 0.1% |
U.S. Treasury Obligations | |
U.S. Treasury Bills, 5.295% (d), 4/11/2024 (e) (Cost $389,192) | | | |
| | |
Securities Lending Collateral 3.0% |
DWS Government & Agency Securities Portfolio "DWS Government Cash Institutional Shares", 5.27% (f) (g) (Cost $12,035,567) | | | |
| | |
|
DWS Central Cash Management Government Fund, 5.38% (f) (Cost $6,216,347) | | | |
| | | |
Total Investment Portfolio (Cost $356,480,560) | | | |
Other Assets and Liabilities, Net | | | |
| | | |
A summary of the Fund’s transactions with affiliated investments during the year ended December 31, 2023 are as follows:
| | | Net Realized
Gain/
(Loss) ($) | Net Change in
Unrealized
Appreciation
(Depreciation) ($) | | Capital Gain
Distributions ($) | Number
of Shares
at
12/31/2023 | |
Securities Lending Collateral 3.0% |
DWS Government & Agency Securities Portfolio "DWS Government Cash Institutional Shares",
5.27% (f) (g) |
| | | | | | | | |
|
DWS Central Cash Management Government Fund, 5.38% (f) |
| | | | | | | | |
| | | | | | | | |
| Non-income producing security. |
| All or a portion of these securities were on loan. In addition, "Other Assets and Liabilities, Net" may include pending sales that are also on loan. The value of securities loaned at December 31, 2023 amounted to $11,042,838, which is 2.8% of net assets. |
| Investment was valued using significant unobservable inputs. |
| Earnout Shares: Will vest based upon the achievement of certain volume-weighted average trading prices (VWAP) for shares of OmniAb Inc. Earnout Shares are not transferrable until the vesting condition for the applicable tranche of Earnout Shares has been achieved. |
| Annualized yield at time of purchase; not a coupon rate. |
| At December 31, 2023, this security has been pledged, in whole or in part, to cover initial margin requirements for open futures contracts. |
| Affiliated fund managed by DWS Investment Management Americas, Inc. The rate shown is the annualized seven-day yield at period end. |
| Represents cash collateral held in connection with securities lending. Income earned by the Fund is net of borrower rebates. |
| Represents the net increase (purchase cost) or decrease (sales proceeds) in the amount invested in cash collateral for the year ended December 31, 2023. |
REIT: Real Estate Investment Trust |
At December 31, 2023, open futures contracts purchased were as follows:
| | | | | | Unrealized
Appreciation ($) |
Russell E-Mini 2000 Index | | | | | | |
Currency Abbreviation(s)
For information on the Fund’s policy and additional disclosures regarding futures contracts, please refer to the Derivatives section of Note B in the accompanying Notes to Financial Statements.
The accompanying notes are an integral part of the financial statements.
Fair Value Measurements
Various inputs are used in determining the value of the Fund's investments. These inputs are summarized in three broad levels. Level 1 includes quoted prices in active markets for identical securities. Level 2 includes other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds and credit risk). Level 3 includes significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments). The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities.
The following is a summary of the inputs used as of December 31, 2023 in valuing the Fund's investments. For information on the Fund's policy regarding the valuation of investments, please refer to the Security Valuation section of Note A in the accompanying Notes to Financial Statements.
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
Government & Agency Obligations | | | | |
Short-Term Investments (a) | | | | |
| | | | |
| | | | |
| | | | |
| See Investment Portfolio for additional detailed categorizations. |
| Derivatives include unrealized appreciation (depreciation) on open futures contracts. |
The accompanying notes are an integral part of the financial statements.
Statement ofAssets and Liabilities as of December 31, 2023
| |
Investments in non-affiliated securities, at value (cost $338,228,646) — including $11,042,838 of securities loaned | |
Investment in DWS Government & Agency Securities Portfolio (cost $12,035,567)* | |
Investment in DWS Central Cash Management Government Fund (cost $6,216,347) | |
| |
Receivable for investments sold | |
Receivable for Fund shares sold | |
| |
| |
| |
| |
| |
Payable upon return of securities loaned | |
Payable for investments purchased | |
Payable for Fund shares redeemed | |
Payable for variation margin on futures contracts | |
| |
| |
Other accrued expenses and payables | |
| |
| |
| |
Distributable earnings (loss) | |
| |
| |
| |
| |
Net Asset Value, offering and redemption price per share ($360,047,260 ÷ 26,423,969 outstanding shares of beneficial interest, no par value, unlimited number of shares authorized) | |
| |
Net Asset Value, offering and redemption price per share ($33,381,592 ÷ 2,450,375 outstanding shares of beneficial interest, no par value, unlimited number of shares authorized) | |
| Represents collateral on securities loaned. |
for the year ended December 31, 2023
| |
| |
Dividends (net of foreign taxes withheld of $7,820) | |
| |
Income distributions — DWS Central Cash Management Government Fund | |
Securities lending income, net of borrower rebates | |
| |
| |
| |
| |
| |
Record keeping fee (Class B) | |
Distribution service fee (Class B) | |
| |
| |
| |
Trustees' fees and expenses | |
| |
Total expenses before expense reductions | |
| |
Total expenses after expense reductions | |
| |
Realized and Unrealized Gain (Loss) | |
Net realized gain (loss) from: | |
| |
| |
| |
Change in net unrealized appreciation (depreciation) on: | |
| |
| |
| |
| |
Net increase (decrease) in net assets resulting from operations | |
The accompanying notes are an integral part of the financial statements.
Statements of Changes in Net Assets
| |
Increase (Decrease) in Net Assets | | |
| | |
| | |
| | |
Change in net unrealized appreciation
(depreciation) | | |
Net increase (decrease) in net assets resulting from operations | | |
Distributions to shareholders: | | |
| | |
| | |
| | |
| | |
| | |
Proceeds from shares sold | | |
Reinvestment of distributions | | |
Payments for shares redeemed | | |
Net increase (decrease) in net assets from Class A share transactions | | |
| | |
Proceeds from shares sold | | |
Reinvestment of distributions | | |
Payments for shares redeemed | | |
Net increase (decrease) in net assets from Class B share transactions | | |
Increase (decrease) in net assets | | |
Net assets at beginning of period | | |
Net assets at end of period | | |
| |
| | |
| | |
Shares outstanding at beginning of period | | |
| | |
Shares issued to shareholders in reinvestment of distributions | | |
| | |
Net increase (decrease) in Class A shares | | |
Shares outstanding at end of period | | |
| | |
Shares outstanding at beginning of period | | |
| | |
Shares issued to shareholders in reinvestment of distributions | | |
| | |
Net increase (decrease) in Class B shares | | |
Shares outstanding at end of period | | |
The accompanying notes are an integral part of the financial statements.
Financial Highlights
DWS Small Cap Index VIP — Class A |
| |
| | | | | |
|
Net asset value, beginning of period | | | | | |
Income (loss) from investment operations: | | | | | |
| | | | | |
Net realized and unrealized gain (loss) | | | | | |
Total from investment operations | | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
Net asset value, end of period | | | | | |
| | | | | |
Ratios to Average Net Assets and Supplemental Data |
Net assets, end of period ($ millions) | | | | | |
Ratio of expenses before expense reductions (%)c | | | | | |
Ratio of expenses after expense reductions (%)c | | | | | |
Ratio of net investment income (%) | | | | | |
Portfolio turnover rate (%) | | | | | |
| Based on average shares outstanding during the period. |
| Total return would have been lower had certain expenses not been reduced. |
| Expense ratio does not reflect charges and fees associated with the separate account that invests in the Fund or any variable life insurance policy or variable annuity contract for which the Fund is an investment option. |
The accompanying notes are an integral part of the financial statements.
DWS Small Cap Index VIP — Class B |
| |
| | | | | |
| | | | | |
Net asset value, beginning of period | | | | | |
Income (loss) from investment operations: | | | | | |
| | | | | |
Net realized and unrealized gain (loss) | | | | | |
Total from investment operations | | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
Net asset value, end of period | | | | | |
| | | | | |
Ratios to Average Net Assets and Supplemental Data |
Net assets, end of period ($ millions) | | | | | |
Ratio of expenses before expense reductions (%)c | | | | | |
Ratio of expenses after expense reductions (%)c | | | | | |
Ratio of net investment income (%) | | | | | |
Portfolio turnover rate (%) | | | | | |
| Based on average shares outstanding during the period. |
| Total return would have been lower had certain expenses not been reduced. |
| Expense ratio does not reflect charges and fees associated with the separate account that invests in the Fund or any variable life insurance policy or variable annuity contract for which the Fund is an investment option. |
The accompanying notes are an integral part of the financial statements.
Notes to Financial Statements
A.
Organization and Significant Accounting Policies
Deutsche DWS Investments VIT Funds (the “Trust”) is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company. The Trust is organized as a Massachusetts business trust. DWS Small Cap Index VIP (the “Fund”) is a diversified series of the Trust offered to investors. The Fund is an underlying investment vehicle for variable annuity contracts and variable life insurance policies to be offered by the separate accounts of certain life insurance companies (“Participating Insurance Companies”).
Multiple Classes of Shares of Beneficial Interest. The Fund offers two classes of shares (Class A shares and Class B shares). Class B shares are subject to Rule 12b-1 distribution fees under the 1940 Act and recordkeeping fees equal to an annual rate of up to 0.25% and of up to 0.15%, respectively, of the average daily net assets of the Class B shares of the Fund. Class A shares are not subject to such fees.
Investment income, realized and unrealized gains and losses, and certain fund-level expenses and expense reductions, if any, are borne pro rata on the basis of relative net assets by the holders of all classes of shares, except that each class bears certain expenses unique to that class (including the applicable 12b-1 distribution fees). Differences in class-level expenses may result in payment of different per share dividends by class. All shares have equal rights with respect to voting subject to class-specific arrangements.
The Fund's financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) which require the use of management estimates. Actual results could differ from those estimates. The Fund qualifies as an investment company under Topic 946 of Accounting Standards Codification of U.S. GAAP. The policies described below are followed consistently by the Fund in the preparation of its financial statements.
Security Valuation. Investments are stated at value determined as of the close of regular trading on the New York Stock Exchange on each day the exchange is open for trading.
The Fund’s Board has designated DWS Investment Management Americas, Inc. (the “Advisor”) as the valuation designee for the Fund pursuant to Rule 2a-5 under the 1940 Act. The Advisor's Pricing Committee (the “Pricing Committee”) typically values securities using readily available market quotations or prices supplied by independent pricing services (which are considered fair values under Rule 2a-5). The Advisor has adopted fair valuation procedures that provide methodologies for fair valuing securities.
Various inputs are used in determining the value of the Fund’s investments. These inputs are summarized in three broad levels. Level 1 includes quoted prices in active markets for identical securities. Level 2 includes other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds and credit risk). Level 3 includes significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments). The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities.
Equity securities are valued at the most recent sale price or official closing price reported on the exchange (U.S. or foreign) or over-the-counter market on which they trade. Securities for which no sales are reported are valued at the calculated mean between the most recent bid and asked quotations on the relevant market or, if a mean cannot be determined, at the most recent bid quotation. Equity securities are generally categorized as Level 1.
Debt securities are valued at prices supplied by independent pricing services approved by the Pricing Committee. Such services may use various pricing techniques which take into account appropriate factors such as yield, quality, coupon rate, maturity, type of issue, trading characteristics, prepayment speeds and other data, as well as broker quotes. If the pricing services are unable to provide valuations, debt securities are valued at the average of the most recent reliable bid quotations or evaluated prices, as applicable, obtained from broker-dealers. These securities are generally categorized as Level 2.
Investments in open-end investment companies are valued at their net asset value each business day and are categorized as Level 1.
Futures contracts are generally valued at the settlement prices established each day on the exchange on which they are traded and are categorized as Level 1.
Securities and other assets for which market quotations are not readily available or for which the above valuation procedures are deemed not to reflect fair value are valued in a manner that is intended to reflect their fair value as determined in accordance with procedures approved by the Pricing Committee and are
generally categorized as Level 3. In accordance with the Fund’s valuation procedures, factors considered in determining value may include, but are not limited to, the type of the security; the size of the holding; the initial cost of the security; the existence of any contractual restrictions on the security’s disposition; the price and extent of public trading in similar securities of the issuer or of comparable companies; quotations or evaluated prices from broker-dealers and/or pricing services; information obtained from the issuer, analysts, and/or the appropriate stock exchange (for exchange-traded securities); an analysis of the company’s or issuer’s financial statements; an evaluation of the forces that influence the issuer and the market(s) in which the security is purchased and sold; and with respect to debt securities, the maturity, coupon, creditworthiness, currency denomination and the movement of the market in which the security is normally traded. The value determined under these procedures may differ from published values for the same securities.
Disclosure about the classification of fair value measurements is included in a table following the Fund's Investment Portfolio.
Securities Lending. Prior to August 17, 2023, Brown Brothers Harriman & Co. served as securities lending agent for the Fund. Effective August 17, 2023, Deutsche Bank AG, as securities lending agent, lends securities of the Fund to certain financial institutions under the terms of its securities lending agreement. During the term of the loans, the Fund continues to receive interest and dividends generated by the securities and to participate in any changes in their market value. The Fund requires the borrowers of the securities to maintain collateral with the Fund consisting of either cash or liquid, unencumbered assets having a value at least equal to the value of the securities loaned. When the collateral falls below specified amounts, the securities lending agent will use its best efforts to obtain additional collateral on the next business day to meet required amounts under the securities lending agreement. During the year ended December 31, 2023, the Fund invested the cash collateral, if any, into a joint trading account in affiliated money market funds, including DWS Government & Agency Securities Portfolio, managed by DWS Investment Management Americas, Inc. DWS Investment Management Americas, Inc. receives a management/administration fee (0.11% annualized effective rate as of December 31, 2023) on the cash collateral invested in DWS Government & Agency Securities Portfolio. The Fund receives compensation for lending its securities either in the form of fees or by earning interest on invested cash collateral net of borrower rebates and fees paid to a securities lending agent. Either the Fund or the borrower may terminate the loan at any time, and the borrower, after notice, is required to return borrowed securities within a standard time period. There may be risks of delay and costs in recovery of securities or even loss of rights in the collateral should the borrower of the securities fail financially. If the Fund is not able to recover securities lent, the Fund may sell the collateral and purchase a replacement investment in the market, incurring the risk that the value of the replacement security is greater than the value of the collateral. The Fund is also subject to all investment risks associated with the reinvestment of any cash collateral received, including, but not limited to, interest rate, credit and liquidity risk associated with such investments.
As of December 31, 2023, the Fund had securities on loan. The value of the related collateral exceeded the value of the securities loaned at period end.
Remaining Contractual Maturity of the Agreements as of December 31, 2023
| | | | | |
Securities Lending Transactions |
| | | | | |
| | | | | |
| | | | | |
Gross amount of recognized liabilities for securities lending transactions: | |
Federal Income Taxes. The Fund is treated as a separate taxpayer as provided for in the Internal Revenue Code of 1986, as amended (the “Code”). It is the Fund's policy to comply with the requirements of the Code, which are applicable to regulated investment companies, and to distribute all of its taxable income to the separate accounts of the Participating Insurance Companies which hold its shares.
The Fund has reviewed the tax positions for the open tax years as of December 31, 2023 and has determined that no provision for income tax and/or uncertain tax positions is required in the Fund's financial statements. The Fund's federal tax returns for the prior three fiscal years remain open subject to examination by the Internal Revenue Service.
Distribution of Income and Gains. Distributions from net investment income of the Fund, if any, are declared and distributed to shareholders annually. Net realized gains from investment transactions, in excess of available capital loss carryforwards, would be taxable to the Fund if not distributed, and, therefore, will be distributed to shareholders at least annually. The Fund may also make additional distributions for tax purposes if necessary.
The timing and characterization of certain income and capital gain distributions are determined annually in accordance with federal tax regulations which may differ from accounting principles generally accepted in the United States of America. These differences primarily relate to certain securities sold at a loss, income received from passive foreign investment companies, investments in derivatives, the realized tax character on distributions from certain securities and income related to restructuring of certain securities. As a result, net investment income (loss) and net realized gain (loss) on investment transactions for a reporting period may differ significantly from distributions during such period. Accordingly, the Fund may periodically make reclassifications among certain of its capital accounts without impacting the net asset value of the Fund.
At December 31, 2023, the Fund's components of distributable earnings (accumulated losses) on a net tax basis were as follows:
Undistributed ordinary income* | |
Undistributed long-term capital gains | |
Net unrealized appreciation (depreciation) on investments | |
At December 31, 2023, the aggregate cost of investments for federal income tax purposes was $362,734,483. The net unrealized appreciation for all investments based on tax cost was $42,672,880. This consisted of aggregate gross unrealized appreciation for all investments for which there was an excess of value over tax cost of $111,744,717 and aggregate gross unrealized depreciation for all investments for which there was an excess of tax cost over value of $69,071,837.
In addition, the tax character of distributions paid to shareholders by the Fund is summarized as follows:
| |
| | |
Distributions from ordinary income* | | |
Distributions from long-term capital gains | | |
| For tax purposes, short-term capital gain distributions are considered ordinary income distributions. |
Contingencies. In the normal course of business, the Fund may enter into contracts with service providers that contain general indemnification clauses. The Fund’s maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Fund that have not yet been made. However, based on experience, the Fund expects the risk of loss to be remote.
Expenses. Expenses of the Trust arising in connection with a specific fund are allocated to that fund. Other Trust expenses which cannot be directly attributed to a fund are apportioned among the funds in the Trust based upon the relative net assets or other appropriate measures.
Real Estate Investment Trusts. The Fund at its fiscal year end recharacterizes distributions received from a Real Estate Investment Trust (“REIT”) investment based on information provided by the REIT into the following categories: ordinary income, long-term and short-term capital gains, and return of capital. If information is not available timely from a REIT, the recharacterization will be estimated for financial reporting purposes and a recharacterization will be made to the accounting records in the following year when such information becomes available. Distributions received from REITs in excess of income are recorded as either a reduction of cost of investments or realized gains.
Other. Investment transactions are accounted for on a trade date plus one basis for daily net asset value calculations. However, for financial reporting purposes, investment transactions are reported on trade date. Interest income is recorded on the accrual basis. Dividend income is recorded on the ex-dividend date net of
foreign withholding taxes. Realized gains and losses from investment transactions are recorded on an identified cost basis. Proceeds from litigation payments, if any, are included in net realized gain (loss) from investments.
A futures contract is an agreement between a buyer or seller and an established futures exchange or its clearinghouse in which the buyer or seller agrees to take or make a delivery of a specific amount of a financial instrument at a specified price on a specific date (settlement date). For the year ended December 31, 2023, the Fund invested in futures to keep cash on hand to meet shareholder redemptions or other needs while maintaining exposure to the stock market.
Upon entering into a futures contract, the Fund is required to deposit with a financial intermediary cash or securities (“initial margin”) in an amount equal to a certain percentage of the face value indicated in the futures contract. Subsequent payments (“variation margin”) are made or received by the Fund dependent upon the daily fluctuations in the value and are recorded for financial reporting purposes as unrealized gains or losses by the Fund. Gains or losses are realized when the contract expires or is closed. Since all futures contracts are exchange-traded, counterparty risk is minimized as the exchange’s clearinghouse acts as the counterparty, and guarantees the futures against default.
Certain risks may arise upon entering into futures contracts, including the risk that an illiquid market will limit the Fund's ability to close out a futures contract prior to the settlement date and the risk that the futures contract is not well correlated with the security, index or currency to which it relates. Risk of loss may exceed amounts recognized in the Statement of Assets and Liabilities.
A summary of the open futures contracts as of December 31, 2023, is included in a table following the Fund’s Investment Portfolio. For the year ended December 31, 2023, the investment in futures contracts purchased had a total notional value generally indicative of a range from approximately $4,946,000 to $11,334,000.
The following table summarizes the value of the Fund's derivative instruments held as of December 31, 2023 and the related location in the accompanying Statement of Assets and Liabilities, presented by primary underlying risk exposure:
| |
| |
The above derivative is located in the following Statement of Assets and Liabilities account: |
| Includes cumulative appreciation of futures contracts as disclosed in the Investment Portfolio. Unsettled variation margin is disclosed separately within the Statement of Assets and Liabilities. |
Additionally, the amount of unrealized and realized gains and losses on derivative instruments recognized in Fund earnings during the year ended December 31, 2023 and the related location in the accompanying Statement of Operations is summarized in the following tables by primary underlying risk exposure:
| |
| |
The above derivative is located in the following Statement of Operations account: |
| Net realized gain (loss) from futures contracts |
Change in Net Unrealized Appreciation (Depreciation) | |
| |
The above derivative is located in the following Statement of Operations account: |
| Change in net unrealized appreciation (depreciation) on futures contracts |
C.
Purchases and Sales of Securities
During the year ended December 31, 2023, purchases and sales of investment securities (excluding short-term investments) aggregated $50,774,203 and $66,365,301, respectively.
Management Agreement. Under the Investment Management Agreement with DWS Investment Management Americas, Inc. (“DIMA” or the “Advisor”), an indirect, wholly owned subsidiary of DWS Group GmbH & Co. KGaA (“DWS Group”), the Advisor determines the securities, instruments and other contracts relating to investments to be purchased, sold or entered into by the Fund or delegates such responsibility to the Fund’s subadvisor. Northern Trust Investments, Inc. (“NTI”) serves as subadvisor. As a subadvisor to the Fund, NTI makes investment decisions and buys and sells securities for the Fund. NTI is paid by the Advisor for the services NTI provides to the Fund.
Under the Investment Management Agreement with the Advisor, the Fund pays the Advisor an annual fee based on the average daily net assets of the Fund, computed and accrued daily and payable monthly at the annual rate (exclusive of any applicable waivers/reimbursements) of 0.28%.
For the period from January 1, 2023 through April 30, 2024, the Advisor has contractually agreed to waive its fees and/or reimburse certain operating expenses of the Fund to the extent necessary to maintain the total annual operating expenses (excluding certain expenses such as extraordinary expenses, taxes, brokerage, interest expense and acquired fund fees and expenses) of each class as follows:
For the year ended December 31, 2023, fees waived and/or expenses reimbursed for each class are as follows:
Administration Fee. Pursuant to an Administrative Services Agreement, DIMA provides most administrative services to the Fund. For all services provided under the Administrative Services Agreement, the Fund pays the Advisor an annual fee (“Administration Fee”) of 0.097% of the Fund’s average daily net assets, computed and accrued daily and payable monthly. For the year ended December 31, 2023, the Administration Fee was $354,234, of which $31,149 is unpaid.
Distribution Service Agreement. DWS Distributors, Inc. (“DDI”), an affiliate of the Advisor, is the Fund’s distributor. In accordance with the Distribution Plan, DDI receives 12b-1 fees of up to 0.25% of the average daily net assets of Class B shares. For the year ended December 31, 2023, the Distribution Service Fee was as follows:
| | Unpaid at
December 31, 2023 |
| | |
Service Provider Fees. DWS Service Company (“DSC”), an affiliate of the Advisor, is the transfer agent, dividend-paying agent and shareholder service agent for the Fund. Pursuant to a sub-transfer agency agreement between DSC and SS&C GIDS, Inc. (“SS&C”), DSC has delegated certain transfer agent, dividend-paying agent and shareholder service agent functions to SS&C. DSC compensates SS&C out of the shareholder servicing fee it receives from the Fund. For the year ended December 31, 2023, the amounts charged to the Fund by DSC were as follows:
| | Unpaid at
December 31, 2023 |
| | |
| | |
| | |
Other Service Fees. Under an agreement with the Fund, DIMA is compensated for providing regulatory filing services to the Fund. For the year ended December 31, 2023, the amount charged to the Fund by DIMA included in the Statement of Operations under “Reports to shareholders” aggregated $4,500, of which $210 is unpaid.
Trustees’ Fees and Expenses. The Fund paid retainer fees to each Trustee not affiliated with the Advisor, plus specified amounts to the Board Chairperson and to each committee Chairperson.
Affiliated Cash Management Vehicles. The Fund may invest uninvested cash balances in DWS Central Cash Management Government Fund and DWS ESG Liquidity Fund, affiliated money market funds which are managed by the Advisor. Each affiliated money market fund is managed in accordance with Rule 2a-7 under the 1940 Act, which governs the quality, maturity, diversity and liquidity of instruments in which a money market fund may invest. DWS Central Cash Management Government Fund seeks to maintain a stable net asset value, and DWS ESG Liquidity Fund maintains a floating net asset value. The Fund indirectly bears its proportionate share of the expenses of each affiliated money market fund in which it invests. DWS Central Cash Management Government Fund does not pay the Advisor an investment management fee. To the extent that DWS ESG Liquidity Fund pays an investment management fee to the Advisor, the Advisor will waive an amount of the investment management fee payable to the Advisor by the Fund equal to the amount of the investment management fee payable on the Fund’s assets invested in DWS ESG Liquidity Fund.
Securities Lending Agent Fees. Effective August 17, 2023, Deutsche Bank AG serves as securities lending agent for the Fund. For the year ended December 31, 2023, the Fund incurred securities lending agent fees to Deutsche Bank AG in the amount of $8,062.
At December 31, 2023, four participating insurance companies were owners of record of 10% or more of the total outstanding Class A shares of the Fund, each owning 33%, 19%, 13% and 11%, respectively. Three participating insurance companies were owners of record of 10% or more of the total outstanding Class B shares of the Fund, each owning 40%, 23% and 21%, respectively.
The Fund and other affiliated funds (the “Participants”) share in a $375 million revolving credit facility provided by a syndication of banks. The Fund may borrow for temporary or emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities. The Participants are charged an annual commitment fee, which is allocated based on net assets, among each of the Participants. Interest is calculated at a daily fluctuating rate per annum equal to the sum of 0.10% plus the higher of the Federal Funds Effective Rate and the Overnight Bank Funding Rate, plus 1.25%. The Fund may borrow up to a maximum of 33 percent of its net assets under the agreement. The Fund had no outstanding loans at December 31, 2023.
Report of Independent Registered Public Accounting Firm
To the Board of Trustees of Deutsche DWS Investments VIT Funds and Shareholders of DWS Small Cap Index VIP:
Opinion on the Financial Statements
We have audited the accompanying statement of assets and liabilities of DWS Small Cap Index VIP (the “Fund”) (one of the funds constituting Deutsche DWS Investments VIT Funds) (the “Trust”), including the investment portfolio, as of December 31, 2023, and the related statement of operations for the year then ended, the statements of changes in net assets for each of the two years in the period then ended, the financial highlights for each of the five years in the period then ended and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund (one of the funds constituting Deutsche DWS Investments VIT Funds) at December 31, 2023, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period then ended and its financial highlights for each of the five years in the period then ended, in conformity with U.S. generally accepted accounting principles.
Basis for Opinion
These financial statements are the responsibility of the Trust’s management. Our responsibility is to express an opinion on the Fund’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Trust in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Trust is not required to have, nor were we engaged to perform, an audit of the Trust’s internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Trust’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our procedures included confirmation of securities owned as of December 31, 2023, by correspondence with the custodian, brokers, and others; when replies were not received from brokers and others, we performed other auditing procedures. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. We have served as the auditor of one or more investment companies in the DWS family of funds since at least 1979, but we are unable to determine the specific year.
Boston, Massachusetts
February 13, 2024
Other Information (Unaudited)
Regulatory Update — Tailored Shareholder Report
Effective January 24, 2023, the SEC amended the rules for mutual fund and exchange-traded fund (“ETF”) annual and semi-annual shareholder reports. The amended rules apply to mutual funds and ETFs that are registered on Form N-1A (i.e., open-end funds) and implement a new streamlined disclosure framework requiring “concise and visually engaging” shareholder reports highlighting key information, including a simplified expense presentation, performance information, portfolio holdings and certain fund statistics. The amended rules seek to simplify shareholder reporting by consolidating investor friendly data in one report and moving other data to Form N-CSR, creating a layered disclosure framework. Certain information from the Fund’s current shareholder reports, including the Fund’s investment portfolio, financial statements and financial highlights, will move to Form N-CSR. This information must be available online, delivered free of charge upon request and filed on a semiannual basis on Form N-CSR. Notably, the amended rules will require mutual funds and ETFs to prepare separate individual shareholder reports for each fund share class. The amendments also include a revised definition of “appropriate broad-based securities market index” that will affect performance presentations in the new streamlined reports and mutual fund and ETF prospectuses. The amended rules and related form amendments have a compliance date of July 24, 2024. At this time, management is evaluating the impact of the amended rules and form amendments on the content of the Fund’s current shareholder reports.
Information About Your Fund’s Expenses (Unaudited)
As an investor of the Fund, you incur two types of costs: ongoing expenses and transaction costs. Ongoing expenses include management fees, distribution and service (12b-1) fees and other Fund expenses. Examples of transaction costs include contract charges, which are not shown in this section. The following tables are intended to help you understand your ongoing expenses (in dollars) of investing in the Fund and to help you compare these expenses with the ongoing expenses of investing in other mutual funds. In the most recent six-month period, the Fund limited these expenses; had it not done so, expenses would have
been higher. The example in the table is based on an investment of $1,000 invested at the beginning of the six-month period and held for the entire period (July 1, 2023 to December 31, 2023).
The tables illustrate your Fund’s expenses in two ways:
—
Actual Fund Return. This helps you estimate the actual dollar amount of ongoing expenses (but not transaction costs) paid on a $1,000 investment in the Fund using the Fund’s actual return during the period. To estimate the expenses you paid over the period, simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the “Expenses Paid per $1,000” line under the share class you hold.
—
Hypothetical 5% Fund Return. This helps you to compare your Fund’s ongoing expenses (but not transaction costs) with those of other mutual funds using the Fund’s actual expense ratio and a hypothetical rate of return of 5% per year before expenses. Examples using a 5% hypothetical fund return may be found in the shareholder reports of other mutual funds. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period.
Please note that the expenses shown in these tables are meant to highlight your ongoing expenses only and do not reflect any transaction costs. The “Expenses Paid per $1,000” line of the tables is useful in comparing ongoing expenses only and will not help you determine the relative total expense of owning different funds. If these transaction costs had been included, your costs would have been higher.
Expenses and Value of a $1,000 Investment for the six months ended December 31, 2023
| | |
Beginning Account Value 7/1/23 | | |
Ending Account Value 12/31/23 | | |
Expenses Paid per $1,000* | | |
Hypothetical 5% Fund Return | | |
Beginning Account Value 7/1/23 | | |
Ending Account Value 12/31/23 | | |
Expenses Paid per $1,000* | | |
| Expenses are equal to the Fund's annualized expense ratio for each share class, multiplied by the average account value over the period, multiplied by 184 (the number of days in the most recent six-month period), then divided by 365. |
Annualized Expense Ratios | | |
| | |
For more information, please refer to the Fund’s prospectus.
These tables do not reflect charges and fees (“contract charges”) associated with the separate account that invests in the Fund or any variable life insurance policy or variable annuity contract for which the Fund is an investment option.
For an analysis of the fees associated with an investment in the Fund or similar funds, please refer to the current and hypothetical expense calculators for Variable Insurance Products which can be found at dws.com/calculators.
Tax Information (Unaudited)
The Fund paid distributions of $0.30 per share from net long-term capital gains during its year ended December 31, 2023.
Pursuant to Section 852 of the Internal Revenue Code, the Fund designates $12,168,000 as capital gain dividends for its year ended December 31, 2023.
For corporate shareholders, 92% of the ordinary dividends (i.e., income dividends plus short-term capital gains) paid during the Fund’s fiscal year ended December 31, 2023, qualified for the dividends received deduction.
Please consult a tax advisor if you have questions about federal or state income tax laws, or on how to prepare your tax returns. If you have specific questions about your account, please contact your insurance provider.
Proxy Voting
The Fund's policies and procedures for voting proxies for portfolio securities and information about how the Fund voted proxies related to its portfolio securities during the most recent 12-month period ended June 30 are available on our Web site — dws.com/en-us/resources/proxy-voting — or on the SEC’s Web site — sec.gov. To obtain a written copy of the Fund's policies and procedures without charge, upon request, call us toll free at (800) 728-3337.
Advisory Agreement Board Considerations and Fee Evaluation
The Board of Trustees (hereinafter referred to as the “Board” or “Trustees”) approved the renewal of DWS Small Cap Index VIP's (the “Fund”) investment management agreement (the “Agreement”) with DWS Investment Management Americas, Inc. (“DIMA”) and sub-advisory agreement (the “Sub-Advisory Agreement” and together with the Agreement, the “Agreements”) between DIMA and Northern Trust Investments, Inc. (“NTI”) in September 2023.
In terms of the process that the Board followed prior to approving the Agreements, shareholders should know that:
—
During the entire process, all of the Fund's Trustees were independent of DIMA and its affiliates (the “Independent Trustees”).
—
The Board met frequently during the past year to discuss fund matters and dedicated a substantial amount of time to contract review matters. Over the course of several months, the Board reviewed extensive materials received from DIMA, independent third parties and independent counsel. These materials included an analysis of the Fund’s performance, fees and expenses, profitability, economies of scale, and fall-out benefits from a fee consultant retained by the Fund’s Independent Trustees (the “Fee Consultant”).
—
The Board also received extensive information throughout the year regarding performance of the Fund.
—
The Independent Trustees regularly met privately with counsel to discuss contract review and other matters. In addition, the Independent Trustees were advised by the Fee Consultant as part of their review of the Fund's contractual arrangements and considered a comprehensive report prepared by the Fee Consultant in connection with their deliberations.
—
In connection with reviewing the Agreements, the Board also reviewed the terms of the Fund's Rule 12b-1 plan, distribution agreement, administrative services agreement, transfer agency agreement and other material service agreements.
In connection with the contract review process, the Board considered the factors discussed below, among others. The Board also considered that DIMA and its predecessors have managed the Fund since its inception, and the Board believes that a long-term relationship with a capable, conscientious advisor is in the best interests of the Fund. The Board considered, generally, that shareholders chose to invest or remain invested in the Fund knowing that DIMA managed the Fund. DIMA is part of DWS Group GmbH & Co. KGaA (“DWS Group”). DWS Group is a global asset management business that offers a wide range of investing expertise and resources, including research capabilities in many countries throughout the world. DWS Group is majority-owned by Deutsche Bank AG, with approximately 20% of its shares publicly traded.
As part of the contract review process, the Board carefully considered the fees and expenses of each DWS fund overseen by the Board in light of the fund’s performance. In many cases, this led to the negotiation and implementation of expense caps.
While shareholders may focus primarily on fund performance and fees, the Fund’s Board considers these and many other factors, including the quality and integrity of DIMA’s and NTI’s personnel and administrative support services provided by DIMA, such as back-office operations, fund valuations, and compliance policies and procedures.
Nature, Quality and Extent of Services. The Board considered the terms of the Agreements, including the scope of advisory services provided under the Agreements. The Board noted that, under the Agreements, DIMA and NTI provide portfolio management services to the Fund and that, pursuant to a separate administrative services agreement, DIMA provides administrative services to the Fund. The Board considered the experience and skills of senior management and investment personnel and the resources made available to such personnel. The Board also considered the risks to DIMA in sponsoring or managing the Fund, including financial, operational and reputational risks, the potential economic impact to DIMA from such risks and DIMA’s approach to addressing such risks. Throughout the course of the year, the Board also received information regarding DIMA’s oversight of fund sub-advisors, including NTI. The Board reviewed the Fund’s performance over short-term and long-term periods and compared those returns to various agreed-upon performance measures, including market index(es) and a peer universe compiled using information supplied by Morningstar Direct (“Morningstar”), an independent fund data service. The Board also noted that it has put into place a process of identifying “Funds in Review” (e.g., funds performing poorly relative to a peer universe), and receives additional reporting from DIMA regarding such funds and, where appropriate, DIMA’s plans to address underperformance. The Board believes this process is an effective manner of identifying and addressing underperforming funds. Based on the information provided, the Board noted that,
for the one-, three- and five-year periods ended December 31, 2022, the Fund’s performance (Class A shares) was in the 4th quartile, 3rd quartile and 3rd quartile, respectively, of the applicable Morningstar universe (the 1st quartile being the best performers and the 4th quartile being the worst performers).
Fees and Expenses. The Board considered the Fund’s investment management fee schedule, sub-advisory fee schedule, operating expenses and total expense ratios, and comparative information provided by Broadridge Financial Solutions, Inc. (“Broadridge”) and the Fee Consultant regarding investment management fee rates paid to other investment advisors by similar funds (1st quartile being the most favorable and 4th quartile being the least favorable). With respect to management fees paid to other investment advisors by similar funds, the Board noted that the contractual fee rates paid by the Fund, which include a 0.097% fee paid to DIMA under the Fund’s administrative services agreement, were higher than the median (4th quartile) of the applicable Broadridge peer group (based on Broadridge data provided as of December 31, 2022). The Board noted that, effective October 1, 2021, in connection with the 2021 contract renewal process, DIMA agreed to reduce the Fund’s contractual management fee by 0.07%. With respect to the sub-advisory fee paid to NTI, the Board noted that the fee is paid by DIMA out of its fee and not directly by the Fund. The Board noted that the Fund’s Class A shares total (net) operating expenses were expected to be higher than the median (3rd quartile) of the applicable Broadridge expense universe (based on Broadridge data provided as of December 31, 2022, and analyzing Broadridge expense universe Class A (net) expenses less any applicable 12b-1 fees) (“Broadridge Universe Expenses”). The Board also reviewed data comparing each other operational share class’s total (net) operating expenses to the applicable Broadridge Universe Expenses. The Board noted that the expense limitations agreed to by DIMA were expected to help the Fund’s total (net) operating expenses remain competitive. The Board considered the Fund’s management fee rate as compared to fees charged by DIMA to comparable DWS U.S. registered funds (“DWS Funds”) and considered differences between the Fund and the comparable DWS Funds. The information requested by the Board as part of its review of fees and expenses also included information about institutional accounts (including any sub-advised funds and accounts) and funds offered primarily to European investors (“DWS Europe Funds”) managed by DWS Group. The Board noted that DIMA indicated that DWS Group does not manage any institutional accounts or DWS Europe Funds comparable to the Fund.
On the basis of the information provided, the Board concluded that management fees were reasonable and appropriate in light of the nature, quality and extent of services provided by DIMA and NTI.
Profitability. The Board reviewed detailed information regarding revenues received by DIMA under the Agreement. The Board considered the estimated costs to DIMA, and pre-tax profits realized by DIMA, from advising the DWS Funds, as well as estimates of the pre-tax profits attributable to managing the Fund in particular. The Board also received information regarding the estimated enterprise-wide profitability of DIMA and its affiliates with respect to all fund services in totality and by fund. The Board and the Fee Consultant reviewed DIMA’s methodology in allocating its costs to the management of the Fund. Based on the information provided, the Board concluded that the pre-tax profits realized by DIMA in connection with the management of the Fund were not unreasonable. The Board also reviewed certain publicly available information regarding the profitability of certain similar investment management firms. The Board noted that, while information regarding the profitability of such firms is limited (and in some cases is not necessarily prepared on a comparable basis), DIMA and its affiliates’ overall profitability with respect to the DWS Funds (after taking into account distribution and other services provided to the funds by DIMA and its affiliates) was lower than the overall profitability levels of most comparable firms for which such data was available. The Board did not consider the profitability of NTI with respect to the Fund. The Board noted that DIMA pays NTI’s fee out of its management fee, and its understanding that the Fund’s sub-advisory fee schedule was the product of an arm’s length negotiation with DIMA.
Economies of Scale. The Board considered whether there are economies of scale with respect to the management of the Fund and whether the Fund benefits from any economies of scale. In this regard, the Board observed that while the Fund’s current investment management fee schedule does not include breakpoints, the Fund’s fee schedule represents an appropriate sharing between the Fund and DIMA of such economies of scale as may exist in the management of the Fund at current asset levels.
Other Benefits to DIMA and NTI and Their Affiliates. The Board also considered the character and amount of other incidental or “fall-out” benefits received by DIMA and NTI and their affiliates, including any fees received by DIMA for administrative services provided to the Fund, any fees received by an affiliate of DIMA for transfer agency services provided to the Fund and any fees received by an affiliate of DIMA for distribution services. The Board also considered benefits to DIMA related to brokerage and soft-dollar allocations, including allocating brokerage to pay for research generated by parties other than the executing broker dealers, which pertain primarily to funds investing in equity securities. In addition, the Board
considered the incidental public relations benefits to DIMA related to DWS Funds advertising and cross-selling opportunities among DIMA products and services. The Board considered these benefits in reaching its conclusion that the Fund’s management fees were reasonable.
Compliance. The Board considered the significant attention and resources dedicated by DIMA to its compliance processes in recent years. The Board noted in particular (i) the experience, seniority and time commitment of the individuals serving as DIMA’s and the Fund’s chief compliance officers; (ii) the substantial commitment of resources by DIMA and its affiliates to compliance matters, including the retention of compliance personnel; and (iii) ongoing efforts to enhance the compliance program. The Board also considered the attention and resources dedicated by DIMA to the oversight of the investment sub-advisor’s compliance program and compliance with the applicable fund policies and procedures.
Based on all of the information considered and the conclusions reached, the Board determined that the continuation of the Agreements is in the best interests of the Fund. In making this determination, the Board did not give particular weight to any single factor identified above. The Board considered these factors over the course of numerous meetings, certain of which were in executive session with only the Independent Trustees and counsel present. It is possible that individual Independent Trustees may have weighed these factors differently in reaching their individual decisions to approve the continuation of the Agreements.
Board Members and Officers
The following table presents certain information regarding the Board Members and Officers of the Trust/Corporation. Each Board Member’s year of birth is set forth in parentheses after his or her name. Unless otherwise noted, (i) each Board Member has engaged in the principal occupation(s) noted in the table for at least the most recent five years, although not necessarily in the same capacity; and (ii) the address of each Independent Board Member is c/o Keith R. Fox, DWS Funds Board Chair, c/o Thomas R. Hiller, Ropes & Gray LLP, Prudential Tower, 800 Boylston Street, Boston, MA 02199-3600. Except as otherwise noted below, the term of office for each Board Member is until the election and qualification of a successor, or until such Board Member sooner dies, resigns, is removed or as otherwise provided in the governing documents of the Trust/Corporation. Because the Fund does not hold an annual meeting of shareholders, each Board Member will hold office for an indeterminate period.
The Board Members may also serve in similar capacities with other funds in the fund complex. The number of funds in the DWS fund complex shown in the table below includes all registered open- and closed-end funds (including all of their portfolios) advised by the Advisor and any registered funds that have an investment advisor that is an affiliated person of the Advisor.
Independent Board Members/Independent Advisory Board Members
Name, Year of
Birth, Position
with the Trust/
Corporation
and Length of
| Business Experience and Directorships
During the Past Five Years | Number of
Funds in
DWS Fund
Complex
Overseen | Other
Directorships
Held by Board
Member |
Keith R. Fox, CFA (1954) Chairperson since 2017, and Board Member since 1996 | Managing General Partner, Exeter Capital Partners (a series of private investment funds) (since 1986); Former Chairman, National Association of Small Business Investment Companies; Former Directorships: ICI Mutual Insurance Company; BoxTop Media Inc. (advertising); Sun Capital Advisers Trust (mutual funds); Progressive International Corporation (kitchen goods designer and distributor) | | |
John W. Ballantine (1946) Board Member since 1999 | Retired; formerly: Executive Vice President and Chief Risk Management Officer, First Chicago NBD Corporation/The First National Bank of Chicago (1996–1998); Executive Vice President and Head of International Banking (1995–1996); Not-for-Profit Directorships: Window to the World Communications (public media); Life Director of Harris Theater for Music and Dance (Chicago); Life Director of Hubbard Street Dance Chicago; Former Directorships: Director and Chairman of the Board, Healthways Inc.2 (population well-being and wellness services) (2003–2014); Stockwell Capital Investments PLC (private equity); Enron Corporation; FNB Corporation; Tokheim Corporation; First Oak Brook Bancshares, Inc.; Oak Brook Bank; Portland General Electric2 (utility company) (2003–2021); and Prisma Energy International; Former Not-for- Profit Directorships: Public Radio International; Palm Beach Civic Assn. | | |
Mary Schmid Daugherty, NACD.DC, PHD, CFA (1958) Board Member or Advisory | Senior Fellow in Applied Finance, Department of Finance, Opus College of Business at the University of St. Thomas (1987–present); Directorships: The Meritex Company (2017–present); Driessen Water, Inc. (2016–present); and The Hardenbergh Foundation (2021–present); Former Directorships: Mairs & Power Funds Trust (mutual funds) (2010–2022); and Crescent Electric Supply Company (2010–2019) | | |
Dawn-Marie Driscoll (1946) Board Member since 1987 | Emeritus Advisory Board and former Executive Fellow, Hoffman Center for Business Ethics, Bentley University; formerly: Partner, Palmer & Dodge (law firm) (1988–1990); Vice President of Corporate Affairs and General Counsel, Filene’s (retail) (1978–1988); Directorships: Trustee and former Chairman of the Board, Southwest Florida Community Foundation (charitable organization); Former Directorships: ICI Mutual Insurance Company (2007–2015); Sun Capital Advisers Trust (mutual funds) (2007–2012); Investment Company Institute (audit, executive, nominating committees) and Independent Directors Council (governance, executive committees) | | |
Name, Year of Birth, Position with the Trust/ Corporation and Length of Time Served1 | Business Experience and Directorships During the Past Five Years | Number of Funds in DWS Fund Complex Overseen | Other Directorships Held by Board Member |
Richard J. Herring (1946) Board Member since 1990 | Jacob Safra Professor of International Banking and Professor of Finance, The Wharton School, University of Pennsylvania (1972–present); formerly: Director, The Wharton Financial Institutions Center (1994–2020); Vice Dean and Director, Wharton Undergraduate Division (1995–2000) and Director, The Lauder Institute of International Management Studies (2000–2006); Member FDIC Systemic Risk Advisory Committee (2011–present), member Systemic Risk Council (2012–present) and member of the Advisory Board of the Yale Program on Financial Stability (2013–present); Former Directorships: Co-Chair of the Shadow Financial Regulatory Committee (2003–2015), Executive Director of The Financial Economists Roundtable (2008–2015), Director of The Thai Capital Fund (2007–2013), Director of The Aberdeen Singapore Fund (2007–2018), Director, The Aberdeen Japan Fund (2007–2021) and Nonexecutive Director of Barclays Bank DE (2010–2018) | | |
Chad D. Perry (1972) Board Member or Advisory | Executive Vice President and General Counsel, RLJ Lodging Trust2 (since 2023); formerly Executive Vice President, General Counsel and Secretary, Tanger Factory Outlet Centers, Inc.2 (2011–2023); Executive Vice President and Deputy General Counsel, LPL Financial Holdings Inc.2 (2006–2011); Senior Corporate Counsel, EMC Corporation (2005–2006); Associate, Ropes & Gray LLP (1997–2005) | | Director, Great Elm Capital Corp. (business development company) (since 2022) |
Rebecca W. Rimel (1951) Board Member since 1995 | Directorships: Washington College (since July 2023); Formerly: Executive Vice President, The Glenmede Trust Company (investment trust and wealth management) (1983–2004); Board Member, Investor Education (charitable organization) (2004–2005); Former Directorships: Trustee, Executive Committee, Philadelphia Chamber of Commerce (2001–2007); Director, Viasys Health Care2 (January 2007–June 2007); Trustee, Thomas Jefferson Foundation (charitable organization) (1994–2012); President, Chief Executive Officer and Director (1994–2020) and Senior Advisor (2020–2021), The Pew Charitable Trusts (charitable organization); Director, BioTelemetry Inc.2 (acquired by Royal Philips in 2021) (healthcare) (2009–2021); Director, Becton Dickinson and Company2 (medical technology company) (2012–2022) | | Director, The Bridgespan Group (nonprofit organization) (since October 2020) |
Catherine Schrand (1964) Board Member since 2021 | Celia Z. Moh Professor of Accounting (2016–present) and Professor of Accounting (1994–present); Directorships: Advisory Board Member, the Jacobs Levy Center, The Wharton School, University of Pennsylvania (since 2023); Former positions: Vice Dean, Wharton Doctoral Programs, The Wharton School, University of Pennsylvania (2016–2019) | | |
William N. Searcy, Jr. (1946) Board Member since 1993 | Private investor since October 2003; formerly: Pension & Savings Trust Officer, Sprint Corporation2 (telecommunications) (November 1989–September 2003); Former Directorships: Trustee, Sun Capital Advisers Trust (mutual funds) (1998–2012) | | |
Officers5
Name, Year of Birth, Position
with the Trust/Corporation
and Length of Time Served6 | Business Experience and Directorships During the
Past Five Years |
Hepsen Uzcan7 (1974) President and Chief Executive Officer, 2017–present | Head of Americas CEO Office, DWS (2023–present), Head of Fund Administration, Head of Product Americas and Head of U.S. Mutual Funds, DWS (2017–present); Vice President, DWS Service Company (2018–present); President, DB Investment Managers, Inc. (2018–present); President and Chief Executive Officer, The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. (2017–present); Vice President, DWS Investment Management Americas, Inc. (2023–present); formerly: Vice President for the Deutsche funds (2016–2017); Assistant Secretary for the DWS funds (2013–2019); Secretary, DWS USA Corporation (2018–2023); Assistant Secretary, DWS Investment Management Americas, Inc. (2018–2023); Assistant Secretary, DWS Trust Company (2018–2023); Assistant Secretary, The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. (2013–2020); Assistant Secretary, DWS Distributors, Inc. (2018–2023); Directorships: Director of DWS Service Company (2018–present); Director of DB Investment Managers, Inc. (2018–present); Director of Episcopalian Charities of New York (2018–present); Interested Director of The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. (2020–present); Director of ICI Mutual Insurance Company (2020–present); Director of DWS USA Corporation (2023–present); Director of DWS Investment Management Americas, Inc. (2023–present); and Manager of DBX Advisors LLC. (2023–present) |
John Millette8 (1962) Vice President and Secretary, 1999–present | Legal (Associate General Counsel), DWS; Chief Legal Officer, DWS Investment Management Americas, Inc. (2015–present); Director and Vice President, DWS Trust Company (2016–present); Secretary, DBX ETF Trust (2020–present); Vice President, DBX Advisors LLC (2021–present); Secretary, The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. (2011–present); formerly: Secretary, Deutsche Investment Management Americas Inc. (2015–2017); and Assistant Secretary, DBX ETF Trust (2019–2020) |
Name, Year of Birth, Position with the Trust/Corporation and Length of Time Served6 | Business Experience and Directorships During the Past Five Years |
Ciara Crawford9 (1984) Assistant Secretary, 2019–present | Fund Administration (Specialist), DWS (2015–present); Assistant Secretary, DWS Service Company (2018–present); Assistant Secretary of U.S. Mutual Funds, DWS (2019–present); Assistant Secretary, DWS USA Corporation (2023–present); Assistant Secretary, DBX Advisors, LLC (2023–present); Assistant Secretary, DWS Investment Management Americas, Inc. (2023–present); Assistant Clerk, DWS Trust Company (2023–present); formerly, Legal Assistant at Accelerated Tax Solutions |
Diane Kenneally8 (1966) Chief Financial Officer and Treasurer, 2018–present | Fund Administration Treasurer's Office (Co-Head since 2018), DWS; Treasurer, Chief Financial Officer and Controller, DBX ETF Trust (2019–present); Treasurer and Chief Financial Officer, The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. (2018–present); formerly: Assistant Treasurer for the DWS funds (2007–2018) |
Yvonne Wong8 (1960) Assistant Treasurer, since December 1, 2023 | Fund Administration (Senior Analyst), DWS; Assistant Treasurer, DBX ETF Trust (since November 14, 2023) |
Sheila Cadogan8 (1966) Assistant Treasurer, 2017–present | Fund Administration Treasurer's Office (Co-Head since 2018), DWS; Director and Vice President, DWS Trust Company (2018–present); Assistant Treasurer, DBX ETF Trust (2019–present); Assistant Treasurer, The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. (2018–present) |
Scott D. Hogan8 (1970) Chief Compliance Officer, 2016–present | Anti-Financial Crime & Compliance US (Senior Team Lead), DWS; Chief Compliance Officer, The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. (2016–present) |
Caroline Pearson8 (1962) Chief Legal Officer, 2010–present | Legal (Senior Team Lead), DWS; Assistant Secretary, DBX ETF Trust (2020–present); Chief Legal Officer, DBX Advisors LLC (2020–present); Chief Legal Officer, The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. (2012–present); formerly: Secretary, Deutsche AM Distributors, Inc. (2002–2017); Secretary, Deutsche AM Service Company (2010–2017); and Chief Legal Officer, DBX Strategic Advisors LLC (2020–2021) |
Christian Rijs7 (1980) Anti-Money Laundering
Compliance Officer, 2021–present | Senior Team Lead Anti-Financial Crime and Compliance, DWS; AML Officer, DWS Trust Company (2021–present); AML Officer, DBX ETF Trust (2021–present); AML Officer, The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. (2021–present); formerly: DWS UK & Ireland Head of Anti-Financial Crime and MLRO |
| The length of time served represents the year in which the Board Member joined the board of one or more DWS funds currently overseen by the Board. |
| A publicly held company with securities registered pursuant to Section 12 of the Securities Exchange Act of 1934. |
| Mr. Perry and Ms. Daugherty are each an Advisory Board Member of Deutsche DWS Asset Allocation Trust, Deutsche DWS Equity 500 Index Portfolio, Deutsche DWS Global/International Fund, Inc., Deutsche DWS Income Trust, Deutsche DWS Institutional Funds, Deutsche DWS International Fund, Inc., Deutsche DWS Investment Trust, Deutsche DWS Investments VIT Funds, Deutsche DWS Money Market Trust, Deutsche DWS Municipal Trust, Deutsche DWS Portfolio Trust, Deutsche DWS Securities Trust, Deutsche DWS Tax Free Trust, Deutsche DWS Variable Series I and Government Cash Management Portfolio. Mr. Perry and Ms. Daugherty are each a Board Member of each other Trust. |
| Mr. Perry and Ms. Daugherty each oversees 21 funds in the DWS Fund Complex as a Board Member of various Trusts. Mr. Perry and Ms. Daugherty are each an Advisory Board Member of various Trusts/Corporations comprised of 47 funds in the DWS Fund Complex. |
| As a result of their respective positions held with the Advisor or its affiliates, these individuals are considered “interested persons” of the Advisor within the meaning of the 1940 Act. Interested persons receive no compensation from the Fund. |
| The length of time served represents the year in which the officer was first elected in such capacity for one or more DWS funds. |
| Address: 875 Third Avenue, New York, New York 10022. |
| Address: 100 Summer Street, Boston, MA 02110. |
| Address: 5201 Gate Parkway, Jacksonville, FL 32256. |
Certain officers hold similar positions for other investment companies for which DIMA or an affiliate serves as the Advisor.
The Fund’s Statement of Additional Information (“SAI”) includes additional information about the Board Members. The SAI is available, without charge, upon request. If you would like to request a copy of the SAI, you may do so by calling the following toll-free number: (800) 728-3337.
vit-scif-2 (R-025818-13 2/24)
| |
| (b) Not applicable |
| |
ITEM 2. | CODE OF ETHICS |
| |
| As of the end of the period covered by this report, the registrant has adopted a code of ethics, as defined in Item 2 of Form N-CSR that applies to its Principal Executive Officer and Principal Financial Officer. There have been no amendments to, or waivers from, a provision of the code of ethics during the period covered by this report that would require disclosure under Item 2. A copy of the code of ethics is filed as an exhibit to this Form N-CSR. |
| |
ITEM 3. | AUDIT COMMITTEE FINANCIAL EXPERT |
| |
| The fund’s audit committee is comprised solely of trustees who are "independent" (as such term has been defined by the Securities and Exchange Commission ("SEC") in regulations implementing Section 407 of the Sarbanes-Oxley Act (the "Regulations")). The fund’s Board of Trustees has determined that there are several "audit committee financial experts" (as such term has been defined by the Regulations) serving on the fund’s audit committee including Ms. Catherine Schrand, the chair of the fund’s audit committee. An “audit committee financial expert” is not an “expert” for any purpose, including for purposes of Section 11 of the Securities Act of 1933 and the designation or identification of a person as an “audit committee financial expert” does not impose on such person any duties, obligations or liability that are greater than the duties, obligations and liability imposed on such person as a member of the audit committee and board of directors in the absence of such designation or identification. |
| |
ITEM 4. | PRINCIPAL ACCOUNTANT FEES AND SERVICES |
| |
DWS Small Cap INdex VIP
form n-csr disclosure re: AUDIT FEES
The following table shows the amount of fees that Ernst & Young LLP (“EY”), the Fund’s Independent Registered Public Accounting Firm, billed to the Fund during the Fund’s last two fiscal years. The Audit Committee approved in advance all audit services and non-audit services that EY provided to the Fund.
Services that the Fund’s Independent Registered Public Accounting Firm Billed to the Fund
Fiscal Year Ended December 31, | Audit Fees Billed to Fund | Audit-Related Fees Billed to Fund | Tax Fees Billed to Fund | All Other Fees Billed to Fund |
2023 | $36,511 | $0 | $8,948 | $0 |
2022 | $36,511 | $0 | $8,316 | $0 |
The above “Tax Fees” were billed for professional services rendered for tax preparation.
Services that the Fund’s Independent Registered Public Accounting Firm Billed to the Adviser and Affiliated Fund Service Providers
The following table shows the amount of fees billed by EY to DWS Investment Management Americas, Inc. (“DIMA” or the “Adviser”), and any entity controlling, controlled by or under common control with DIMA (“Control Affiliate”) that provides ongoing services to the Fund (“Affiliated Fund Service Provider”), for engagements directly related to the Fund’s operations and financial reporting, during the Fund’s last two fiscal years.
Fiscal Year Ended December 31, | Audit-Related Fees Billed to Adviser and Affiliated Fund Service Providers | Tax Fees Billed to Adviser and Affiliated Fund Service Providers | All Other Fees Billed to Adviser and Affiliated Fund Service Providers |
2023 | $0 | $424,143 | $0 |
2022 | $0 | $148,212 | $0 |
The above “Tax Fees” were billed in connection with tax compliance services and agreed upon procedures.
Non-Audit Services
The following table shows the amount of fees that EY billed during the Fund’s last two fiscal years for non-audit services. The Audit Committee pre-approved all non-audit services that EY provided to the Adviser and any Affiliated Fund Service Provider that related directly to the Fund’s operations and financial reporting. The Audit Committee requested and received information from EY about any non-audit services that EY rendered during the Fund’s last fiscal year to the Adviser and any Affiliated Fund Service Provider. The Committee considered this information in evaluating EY’s independence.
Fiscal Year Ended December 31 | Total Non-Audit Fees Billed to Fund (A) | Total Non-Audit Fees billed to Adviser and Affiliated Fund Service Providers (engagements related directly to the operations and financial reporting of the Fund) (B) | Total Non-Audit Fees billed to Adviser and Affiliated Fund Service Providers (all other engagements) (C) | Total of (A), (B) and (C) |
2023 | $8,948 | $424,143 | $0 | $433,091 |
2022 | $8,316 | $148,212 | $0 | $156,528 |
All other engagement fees were billed for services in connection with agreed upon procedures and tax compliance for DIMA and other related entities.
Audit Committee Pre-Approval Policies and Procedures. Generally, each Fund’s Audit Committee must pre approve (i) all services to be performed for a Fund by a Fund’s Independent Registered Public Accounting Firm and (ii) all non-audit services to be performed by a Fund’s Independent Registered Public Accounting Firm for the DIMA Entities with respect to operations and financial reporting of the Fund, except that the Chairperson or Vice Chairperson of each Fund’s Audit Committee may grant the pre-approval for non-audit services described in items (i) and (ii) above for non-prohibited services for engagements of less than $100,000. All such delegated pre approvals shall be presented to each Fund’s Audit Committee no later than the next Audit Committee meeting.
There were no amounts that were approved by the Audit Committee pursuant to the de minimis exception under Rule 2-01 of Regulation S-X.
According to the registrant’s principal Independent Registered Public Accounting Firm, substantially all of the principal Independent Registered Public Accounting Firm's hours spent on auditing the registrant's financial statements were attributed to work performed by full-time permanent employees of the principal Independent Registered Public Accounting Firm and (i) and (j) are not applicable.
***
In connection with the audit of the 2022 and 2023 financial statements, the Fund entered into an engagement letter with EY. The terms of the engagement letter required by EY, and agreed to by the Audit Committee, include a provision mandating the use of mediation and arbitration to resolve any controversy or claim between the parties arising out of or relating to the engagement letter or services provided thereunder.
***
Pursuant to PCAOB Rule 3526, EY is required to describe in writing to the Fund’s Audit Committee, on at least an annual basis, all relationships between EY, or any of its affiliates, and the DWS Funds, including the Fund, or persons in financial reporting oversight roles at the DWS Funds that, as of the date of the communication, may reasonably be thought to bear on EY’s independence. Pursuant to PCAOB Rule 3526, EY has reported the matters set forth below that may reasonably be thought to bear on EY’s independence. With respect to each reported matter in the aggregate, EY advised the Audit Committee that, after careful consideration of the facts and circumstances and the applicable independence rules, it concluded that the matters do not and will not impair EY’s ability to exercise objective and impartial judgement in connection with the audits of the financial statements for the Fund and a reasonable investor with knowledge of all relevant facts and circumstances would conclude that EY has been and is capable of exercising objective and impartial judgment on all issues encompassed within EY’s audit engagements. EY also confirmed to the Audit Committee that it can continue to act as the Independent Registered Public Accounting Firm for the Fund.
| · | EY advised the Fund’s Audit Committee that various covered persons within EY and EY’s affiliates held investments in, or had other financial relationships with, entities within the DWS Funds “investment company complex” (as defined in Regulation S-X) (the “DWS Funds Complex”). EY informed the Audit Committee that these investments and financial relationships were inconsistent with Rule 2-01(c)(1) of Regulation S-X. EY reported that all breaches have been resolved and that none of the breaches involved any professionals who were part of the audit engagement team for the Fund or in the position to influence the audit engagement team for the Fund. |
| |
ITEM 5. | AUDIT COMMITTEE OF LISTED REGISTRANTS |
| |
| Not applicable |
| |
ITEM 6. | INVESTMENTS |
| |
| Not applicable |
| |
ITEM 7. | DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES |
| |
| Not applicable |
| |
ITEM 8. | PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES |
| |
| Not applicable |
| |
ITEM 9. | PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS |
| |
| Not applicable |
| |
ITEM 10. | SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS |
| |
| There were no material changes to the procedures by which shareholders may recommend nominees to the Fund’s Board. The primary function of the Nominating and Governance Committee is to identify and recommend individuals for membership on the Board and oversee the administration of the Board Governance Guidelines. Shareholders may recommend candidates for Board positions by forwarding their correspondence by U.S. mail or courier service to Keith R. Fox, DWS Funds Board Chair, c/o Thomas R. Hiller, Ropes & Gray LLP, Prudential Tower, 800 Boylston Street, Boston, MA 02199-3600. |
| |
ITEM 11. | CONTROLS AND PROCEDURES |
| |
| (a) | The Chief Executive and Financial Officers concluded that the Registrant’s Disclosure Controls and Procedures are effective based on the evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report. |
| |
| (b) | There have been no changes in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal controls over financial reporting. |
| |
ITEM 12. | Disclosure of Securities Lending Activities for Closed-End Management Investment Companies |
| |
| Not applicable |
| |
ITEM 13. | EXHIBITS |
| |
| (a)(1) | Code of Ethics pursuant to Item 2 of Form N-CSR is filed and attached hereto as EX-99.CODE ETH. |
| |
| (a)(2) | Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT. |
| |
| (b) | Certification pursuant to Rule 30a-2(b) under the Investment Company Act of 1940 (17 CFR 270.30a-2(b)) is furnished and attached hereto as Exhibit 99.906CERT. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Registrant: | DWS Small Cap Index VIP, a series of Deutsche DWS Investments VIT Funds |
| |
| |
By: | /s/Hepsen Uzcan Hepsen Uzcan President |
| |
Date: | 2/15/2024 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: | /s/Hepsen Uzcan Hepsen Uzcan President |
| |
Date: | 2/15/2024 |
| |
| |
| |
By: | /s/Diane Kenneally Diane Kenneally Chief Financial Officer and Treasurer |
| |
Date: | 2/15/2024 |